Delaware
|
| |
7371
|
| |
88-2789488
|
(State or Other Jurisdiction of Incorporation or Organization)
|
| |
(Primary Standard Industrial Classification Code Number)
|
| |
(I.R.S. Employer
Identification Number)
|
Large accelerated filer
|
| |
☐
|
| |
|
| |
Accelerated filer
|
| |
☐
|
Non-accelerated filer
|
| |
☒
|
| |
|
| |
Smaller reporting company
|
| |
☒
|
|
| |
|
| |
|
| |
Emerging growth company
|
| |
☒
|
•
|
our relatively short operating history in a rapidly evolving industry, which makes it difficult to evaluate our future
prospects and may increase the risk that we will not be successful, and the possibility that we may not be able to generate sufficient revenue to become profitable or maintain profitability in the future;
|
•
|
the possibility that if we do not successfully develop and deploy new software, platform features or services to address the
needs of our clients, if we fail to retain our existing clients or acquire new clients, and/or if we fail to expand effectively into new markets, our revenue may decrease and our business may be harmed;
|
•
|
our significant working capital deficiency and history of losses, and the possibility that we may need to raise additional
funds to meet our obligations and sustain our operations, and may not achieve profitability in the future;
|
•
|
the possibility that federal law enforcement may deem our clients to be in violation of U.S. federal law, and, in particular
the CSA, and that a change in U.S. federal policy on cannabis enforcement and strict enforcement of federal cannabis laws against our clients would undermine our business model and materially affect our business and operations;
|
•
|
the possibility that some of our clients currently and in the future may not be in compliance with licensing and related
requirements under applicable laws and regulations; and
|
•
|
other risks and uncertainties indicated from time to time in filings made with the SEC.
|
•
|
SpringBig’s platform offers retailers text message marketing, which allows clients to send promotions to existing
customers. This text messaging platform offers a variety of features, including multiple customer segmentations, which automatically groups customers into segments based on their preferences and purchase behavior. Retailers also have
access to the “autoconnects” feature, which allows them to easily leverage customer data and send messages directly to consumers based on certain actions and also includes functionality to help clients identify opportunities to send
text messages. SpringBig also provides an e-signature app, designed to accommodate proper ‘double opt-in’ procedure, through both implied and expressed consent to facilitate compliance with the TCPA, FCC, and Canadian CRTC.
|
•
|
The consumer application (or wallet) offered by SpringBig allows customers to access and check their points, redeem
rewards, and view upcoming offers. The wallet fully integrates with cannabis e-commerce providers, allowing customers to place orders directly from their wallet. Retailers can customize this application with a distinct icon, name,
layout, and color scheme, thus allowing for brand consistency and a higher-quality and frictionless customer experience.
|
•
|
Retailers can use the SpringBig platform to compile marketing campaigns based on consumer profiles and preferences. Once a
campaign launches, retailers are able to analyze in-depth data in order to measure campaign success. Enterprise Resource Planning (or ERP)-level customer data management and analysis also allow retailers to organize their sales funnel
and provide a personalized, targeted approach to marketing campaigns.
|
•
|
SpringBig’s platform integrates with many point of sale (“POS”) systems used in the cannabis industry, allowing retailers
to automatically collect additional data on consumers.
|
•
|
SpringBig has a brand marketing platform that offers a direct-to-consumer marketing automation platform specifically for
cannabis brands. This direct-to-consumer marketing engine allows brands to target and measure the complete transaction cycle from initial engagement through point of sale.
|
•
|
SpringBig provides brands with the opportunity to provide content that, in turn, SpringBig’s retail clients can utilize in
their targeted consumer marketing campaigns. This provides the brand with access to the consumer and that can be leveraged through the brand and retailer cooperating in a promotional campaign on the SpringBig platform. The SpringBig
platform can be used by brands to increase their brand awareness, expand retail partnerships, and acquire and retain new customers. The SpringBig brands platform also provides brand clients with access to detailed reports regarding
campaign attribution metrics.
|
•
|
We have a relatively short operating history in a rapidly evolving industry, which makes it difficult to evaluate our
future prospects and may increase the risk that we will not be successful. We may not be able to generate sufficient revenue to become profitable or maintain profitability in the future.
|
•
|
If we do not successfully develop and deploy new software, platform features or services to address the needs of our
clients, if we fail to retain our existing clients or acquire new clients, and/or if we fail to expand effectively into new markets, our revenue may decrease and our business may be harmed.
|
•
|
We have a significant working capital deficiency and a history of losses, may need to raise additional funds to meet our
obligations and sustain our operations, and may not achieve profitability in the future.
|
•
|
Federal law enforcement may deem our clients to be in violation of U.S. federal law, and, in particular the CSA. A change
in U.S. federal policy on cannabis enforcement and strict enforcement of federal cannabis laws against our clients would undermine our business model and materially affect our business and operations.
|
•
|
Some of our clients currently and in the future may not be in compliance with licensing and related requirements under
applicable laws and regulations. We further cannot ensure that our clients will conduct their business in a way that complies with all laws. Allowing unlicensed or noncompliant businesses to access our platform and services, or
allowing businesses to use our solutions in a noncompliant manner, may subject us to legal or regulatory enforcement and negative publicity, which could adversely impact our business, operating results, financial condition, brand and
reputation.
|
•
|
Our business is dependent on U.S. state laws and regulations and Canadian federal and provincial laws and regulations
pertaining to the cannabis industry, its continued legalization, and the rapid changes in applicable laws and regulations may increase the risk that we will not be successful. We are subject to various standards, laws and regulations
and any actual or perceived failure to comply with such obligations could harm our business.
|
•
|
Our business is dependent on the market acceptance of cannabis consumers and negative trends could adversely affect our
business operations.
|
•
|
Our business is highly dependent upon our brand recognition and reputation, and any erosion or degradation of our brand
recognition or reputation would likely adversely affect our business and operating results.
|
•
|
We face competition in marketing and advertising services available to our clients, and we expect competition to further
intensify as the cannabis industry continues to evolve.
|
•
|
If we fail to predict and/or manage our growth effectively, our brand, business and operating results could be harmed.
|
•
|
If we are unable to recruit, train, retain and motivate key personnel, we may not achieve our business objectives.
|
•
|
If our current marketing model is not effective in attracting new clients, we may need to employ higher-cost sales and
marketing methods to attract and retain clients, which could adversely affect our profitability.
|
•
|
We may be unable to scale and adapt our existing technology and network infrastructure in a timely or effective manner to
ensure that our platform is accessible, which would harm our reputation, business and operating results.
|
•
|
Real or perceived errors, failures, or bugs in our platform or cyber security breaches, unauthorized access or other events
could adversely affect our operating results and growth prospects and/or subject us to significant liability.
|
•
|
The impact of global, regional or local economic and market conditions or events may adversely affect our business,
operating results and financial condition.
|
•
|
We may improve our products and solutions in ways that forego short-term gains.
|
•
|
Future investments in our growth strategy, including acquisitions, could disrupt our business and adversely affect our
operating results, financial condition and cash flows.
|
•
|
the efficacy of our marketing efforts;
|
•
|
our ability to maintain a high-quality, innovative, and error- and bug-free platform and similarly high quality client
service;
|
•
|
our ability to maintain high satisfaction among clients (and our clients’ consumers);
|
•
|
the quality and perceived value of our platforms and services;
|
•
|
successfully implementing and developing new features and revenue streams;
|
•
|
our ability to obtain, maintain and enforce trademarks and other indicia of origin that are valuable to our brand;
|
•
|
our ability to successfully differentiate our platforms and services from competitors’ offerings;
|
•
|
our ability to continue to integrate with POS systems;
|
•
|
our ability to provide our clients with accurate and actionable insights from the consumer data and feedback collected
through our platform;
|
•
|
our compliance with laws and regulations;
|
•
|
our ability to address any environmental, social, and governance expectations of our various stakeholders;
|
•
|
our ability to provide client support; and
|
•
|
any actual or perceived data breach or data loss, or misuse or perceived misuse of our platforms.
|
•
|
actions of competitors or other third parties;
|
•
|
consumers’ experiences with retailers or brands using our platform;
|
•
|
positive or negative publicity, including with respect to events or activities attributed to us, our employees, partners or
others associated with any of these parties;
|
•
|
interruptions, delays or attacks on our platforms; and
|
•
|
litigation or regulatory developments.
|
•
|
the efficacy of our marketing efforts;
|
•
|
our ability to maintain a high-quality, innovative, and error- and bug-free platform and similarly high quality client
service;
|
•
|
our ability to maintain high satisfaction among clients (and our clients’ consumers);
|
•
|
the quality and perceived value of our platforms and services;
|
•
|
successfully implementing and developing new features and revenue streams;
|
•
|
our ability to obtain, maintain and enforce trademarks and other indicia of origin that are valuable to our brand;
|
•
|
our ability to successfully differentiate our platforms and services from competitors’ offerings;
|
•
|
our ability to integrate with POS systems;
|
•
|
our ability to provide our clients with accurate and actionable insights from the consumer data and feedback collected
through our platform;
|
•
|
our compliance with laws and regulations;
|
•
|
our ability to address any environmental, social, and governance expectations of our various stakeholders;
|
•
|
our ability to provide client support; and
|
•
|
any actual or perceived data breach or data loss, or misuse or perceived misuse of our platforms.
|
•
|
actions of competitors or other third parties;
|
•
|
consumers’ experiences with retailers or brands using our platform;
|
•
|
public perception of cannabis and cannabis-related businesses;
|
•
|
positive or negative publicity, including with respect to events or activities attributed to us, our employees, partners or
others associated with any of these parties;
|
•
|
interruptions, delays or attacks on our platforms; and
|
•
|
litigation or regulatory developments.
|
•
|
our ability to attract new clients and retain existing clients;
|
•
|
our ability to accurately forecast revenue and appropriately plan our expenses;
|
•
|
the effects of increased competition on our business;
|
•
|
our ability to successfully expand in existing markets and successfully enter new markets;
|
•
|
the impact of global, regional or economic conditions;
|
•
|
the ability of licensed cannabis markets to successfully grow and outcompete illegal cannabis markets;
|
•
|
our ability to protect our intellectual property;
|
•
|
our ability to maintain and effectively manage an adequate rate of growth;
|
•
|
our ability to maintain and increase traffic to our platform;
|
•
|
costs associated with defending claims, including intellectual property infringement claims and related judgments or
settlements;
|
•
|
changes in governmental or other regulation affecting our business;
|
•
|
interruptions in platform availability and any related impact on our business, reputation or brand;
|
•
|
the attraction and retention of qualified personnel;
|
•
|
the effects of natural or man-made catastrophic events and/or health crises (including COVID-19); and
|
•
|
the effectiveness of our internal controls.
|
•
|
an acquisition may negatively affect our operating results, financial condition or cash flows because it may require us to
incur charges or assume substantial debt or other liabilities, may cause adverse tax consequences or unfavorable accounting treatment, may expose us to claims and disputes by third parties, including intellectual property claims and
disputes, or may not generate sufficient financial return to offset additional costs and expenses related to the acquisition;
|
•
|
we may encounter difficulties or unforeseen expenditures in integrating the business, technologies, products, personnel or
operations of any company that we acquire, particularly if key personnel of the acquired company decide not to work for us, and potentially across different cultures and languages in the event of a foreign acquisition;
|
•
|
the acquired business may not perform at levels and on the timelines anticipated by our management and/or we may not be able
to achieve expected synergies;
|
•
|
an acquisition may disrupt our ongoing business, divert resources, increase our expenses and distract our management;
|
•
|
an acquisition may result in a delay or reduction of sales for both us and the company we acquire due to uncertainty about
continuity and effectiveness of products or support from either company;
|
•
|
we may encounter difficulties in, or may be unable to, successfully sell any acquired products or services;
|
•
|
an acquisition may involve the entry into geographic or business markets in which we have little or no prior experience or
where competitors have stronger market positions;
|
•
|
potential strain on our financial and managerial controls and reporting systems and procedures;
|
•
|
potential known and unknown liabilities associated with an acquired company;
|
•
|
if we incur debt to fund such acquisitions, such debt may subject us to material restrictions on our ability to conduct our
business as well as financial maintenance covenants;
|
•
|
the risk of impairment charges related to potential write-downs of acquired assets or goodwill in future acquisitions;
|
•
|
to the extent that we issue a significant amount of equity or convertible debt securities in connection with future
acquisitions, existing equity holders may be diluted and earnings per share may decrease; and
|
•
|
managing the varying intellectual property protection strategies and other activities of an acquired company.
|
•
|
actual or anticipated fluctuations in our quarterly and annual financial results or the quarterly and annual financial
results of companies perceived to be similar to us;
|
•
|
changes in the market’s expectations about operating results;
|
•
|
operating results failing to meet market expectations in a particular period, which could impact the market price our shares
of common stock;
|
•
|
operating and stock price performance of other companies that investors deem comparable to us;
|
•
|
changes in laws and regulations affecting our businesses;
|
•
|
commencement of, or involvement in, litigation involving the Company;
|
•
|
changes in our capital structure, such as future issuances of securities or the incurrence of debt;
|
•
|
any significant change in our Board of Directors or management;
|
•
|
sales of substantial amounts of our shares of common stock by the Company or our directors, executive officers or significant
shareholders or the perception that such sales could occur; and
|
•
|
general economic and political conditions such as recessions, interest rates, fuel prices, inflation, international currency
fluctuations and acts of war or terrorism.
|
•
|
a classified Board of Directors with staggered three-year terms;
|
•
|
the ability of our Board of Directors to determine the powers, preferences and rights of preference shares and to cause us to
issue the preference shares without shareholder approval; and
|
•
|
requiring advance notice for shareholder proposals and nominations and placing limitations on convening shareholder meetings.
|
|
| |
Three Months Ended March 31,
|
|||
|
| |
2024
|
| |
2023
|
Revenue
|
| |
$6,474
|
| |
$7,157
|
Net income (loss)
|
| |
417
|
| |
(2,262)
|
Adjusted EBITDA
|
| |
150
|
| |
(1,331)
|
|
| |
|
| |
|
Number of retail clients
|
| |
1,207
|
| |
1,366
|
Net revenue retention
|
| |
89%
|
| |
100%
|
Number of messages (million)
|
| |
637
|
| |
488
|
|
| |
Years Ended December 31,
|
|||
|
| |
2023
|
| |
2022
|
Revenue
|
| |
$28,050
|
| |
$26,629
|
Net loss
|
| |
(10,233)
|
| |
(13,076)
|
Adjusted EBITDA
|
| |
(3,628)
|
| |
(12,603)
|
|
| |
|
| |
|
Number of retail clients
|
| |
1,298
|
| |
1,319
|
Net revenue retention
|
| |
97%
|
| |
105%
|
Number of messages (million)
|
| |
2,388
|
| |
2,099
|
•
|
although depreciation and amortization are non-cash charges, the assets being depreciated may have to be replaced in the
future, and neither EBITDA nor Adjusted EBITDA reflect cash capital expenditure requirements for such replacements or for new capital expenditure requirements;
|
•
|
EBITDA and Adjusted EBITDA do not reflect changes in, or cash requirements for, our working capital needs; and
|
•
|
EBITDA and Adjusted EBITDA do not reflect tax payments that may represent a reduction in cash available.
|
|
| |
Three Months Ended March 31,
|
|||
|
| |
2024
|
| |
2023
|
Net income (loss)
|
| |
$417
|
| |
$(2,262)
|
Interest income
|
| |
(4)
|
| |
(10)
|
Interest expense
|
| |
875
|
| |
391
|
Depreciation expense
|
| |
54
|
| |
66
|
EBITDA
|
| |
1,342
|
| |
(1,815)
|
Stock-based compensation*
|
| |
195
|
| |
162
|
Bad debt expense
|
| |
87
|
| |
169
|
Gain on repurchase of convertible debt
|
| |
(1,573)
|
| |
—
|
Severance and related payments
|
| |
96
|
| |
—
|
Change in fair value of warrants
|
| |
3
|
| |
153
|
Adjusted EBITDA
|
| |
$150
|
| |
$(1,331)
|
*
|
Stock-based compensation is recorded in General and administrative expenses
|
|
| |
Years Ended December 31,
|
|||
|
| |
2023
|
| |
2022
|
Net loss
|
| |
$(10,233)
|
| |
$(13,076)
|
Interest income
|
| |
(24)
|
| |
(18)
|
Interest expense
|
| |
2,247
|
| |
949
|
Income tax expense
|
| |
4
|
| |
3
|
Depreciation and amortization expense
|
| |
272
|
| |
259
|
|
| |
Years Ended December 31,
|
|||
|
| |
2023
|
| |
2022
|
EBITDA
|
| |
(7,734)
|
| |
(11,883)
|
Stock-based compensation*
|
| |
821
|
| |
1,226
|
Bad debt expense
|
| |
1,563
|
| |
1,474
|
Severance payments
|
| |
494
|
| |
188
|
Other non-recurring, non-operating expenses and asset impairment
|
| |
512
|
| |
550
|
Settlement of litigation, including legal costs
|
| |
1,050
|
| |
—
|
Change in fair value of warrants
|
| |
(334)
|
| |
(4,158)
|
Adjusted EBITDA
|
| |
$(3,628)
|
| |
$(12,603)
|
*
|
Stock-based compensation is recorded in General and administrative expenses
|
|
| |
Three Months Ended March 31,
|
|||||||||
|
| |
2024
|
| |
2023
|
| |
Increase (decrease)
|
| |
%
|
|
| |
(in thousands)
|
|||||||||
Revenue
|
| |
$6,474
|
| |
$7,157
|
| |
$(683)
|
| |
(10)%
|
Cost of revenue
|
| |
1,794
|
| |
1,350
|
| |
444
|
| |
33%
|
Gross profit
|
| |
4,680
|
| |
5,807
|
| |
(1,127)
|
| |
(19)%
|
Operating expenses:
|
| |
|
| |
|
| |
|
| |
|
Selling, servicing and marketing
|
| |
1,527
|
| |
2,478
|
| |
(951)
|
| |
(38)%
|
Technology and software development
|
| |
1,666
|
| |
2,300
|
| |
(634)
|
| |
(28)%
|
General and administrative
|
| |
1,769
|
| |
2,757
|
| |
(988)
|
| |
(36)%
|
Total operating expenses
|
| |
4,962
|
| |
7,535
|
| |
(2,573)
|
| |
(34)%
|
|
| |
Three Months Ended March 31,
|
|||||||||
|
| |
2024
|
| |
2023
|
| |
Increase (decrease)
|
| |
%
|
|
| |
(in thousands)
|
|||||||||
Loss from operations
|
| |
(282)
|
| |
(1,728)
|
| |
1,446
|
| |
(84)%
|
Interest income
|
| |
4
|
| |
10
|
| |
(6)
|
| |
(60)%
|
Interest expense
|
| |
(875)
|
| |
(391)
|
| |
(484)
|
| |
nm
|
Gain on note repurchase
|
| |
1,573
|
| |
—
|
| |
1,573
|
| |
nm
|
Change in fair value of warrants
|
| |
(3)
|
| |
(153)
|
| |
150
|
| |
nm
|
Income (loss) before taxes
|
| |
417
|
| |
(2,262)
|
| |
2,679
|
| |
nm
|
Provision for income taxes
|
| |
—
|
| |
—
|
| |
—
|
| |
—
|
Income (loss) after taxes
|
| |
$417
|
| |
$(2,262)
|
| |
$2,679
|
| |
nm
|
|
nm-not meaningful
|
|
| |
Years Ended December 31,
|
|||||||||
|
| |
2023
|
| |
2022
|
| |
Increase (decrease)
|
| |
%
|
|
| |
(in thousands)
|
| |
(in thousands)
|
| |
(in thousands)
|
| |
|
Revenue
|
| |
$28,050
|
| |
$26,629
|
| |
$1,421
|
| |
5%
|
Cost of revenues
|
| |
6,486
|
| |
6,701
|
| |
(215)
|
| |
(3)%
|
Gross profit
|
| |
21,564
|
| |
19,928
|
| |
1,636
|
| |
8%
|
Operating expenses:
|
| |
|
| |
|
| |
|
| |
|
Selling, servicing and marketing
|
| |
8,278
|
| |
12,333
|
| |
(4,055)
|
| |
(33)%
|
Technology and software development
|
| |
8,011
|
| |
11,353
|
| |
(3,342)
|
| |
(29)%
|
General and administrative
|
| |
13,615
|
| |
12,542
|
| |
1,073
|
| |
9%
|
Total operating expenses
|
| |
29,904
|
| |
36,228
|
| |
(6,324)
|
| |
(17)%
|
Loss from operations
|
| |
(8,340)
|
| |
(16,300)
|
| |
7,960
|
| |
(49)%
|
Interest income
|
| |
24
|
| |
18
|
| |
6
|
| |
33%
|
Interest expense
|
| |
(2,247)
|
| |
(949)
|
| |
(1,298)
|
| |
137%
|
Change in fair value of warrants
|
| |
334
|
| |
4,158
|
| |
(3,824)
|
| |
(92)%
|
Loss before income tax
|
| |
(10,229)
|
| |
(13,073)
|
| |
2,844
|
| |
(22)%
|
Income tax expense
|
| |
4
|
| |
3
|
| |
1
|
| |
nm
|
Net loss
|
| |
$(10,233)
|
| |
$(13,076)
|
| |
$2,843
|
| |
(22)%
|
|
nm - not meaningful
|
|
| |
March 31,
2024
|
| |
December 31,
2023
|
Cash and cash equivalents
|
| |
$1,668
|
| |
$331
|
Accounts receivable, net
|
| |
3,211
|
| |
2,948
|
Working capital
|
| |
(1,362)
|
| |
(9,106)
|
|
| |
Three Months Ended March 31,
|
|||
|
| |
2024
|
| |
2023
|
Statement of Cash Flows Data:
|
| |
|
| |
|
Total cash (used in) provided by:
|
| |
|
| |
|
Operating activities
|
| |
$(1,878)
|
| |
$379
|
Investing activities
|
| |
(59)
|
| |
(12)
|
Financing activities
|
| |
3,274
|
| |
(1,344)
|
Increase (decrease) in cash and cash equivalents
|
| |
$1,337
|
| |
$(977)
|
|
| |
Years Ended December 31,
|
|||
|
| |
2023
|
| |
2022
|
Statement of Cash Flows Data:
|
| |
|
| |
|
Total cash (used in) provided by:
|
| |
|
| |
|
Operating activities
|
| |
$(3,976)
|
| |
$(14,518)
|
Investing activities
|
| |
(351)
|
| |
(413)
|
Financing activities
|
| |
1,112
|
| |
16,250
|
Increase (decrease) in cash and cash equivalents
|
| |
$(3,215)
|
| |
$1,319
|
•
|
Cannabis retailers and brands lack actionable data and need better insight and recommendation technology.
|
•
|
Purpose-built marketing technology and targeting is necessary to improve consumer acquisition and retention.
|
•
|
The cannabis industry lacks robust fintech solutions, including processing of payments and consumer credit.
|
Name
|
| |
Age
|
| |
Position
|
Executive Officers
|
| |
|
| |
|
Jeffrey Harris
|
| |
60
|
| |
Chief Executive Officer and Director
|
Paul Sykes
|
| |
58
|
| |
Chief Financial Officer
|
Non-Employee Directors
|
| |
|
| |
|
Shawn Dym
|
| |
43
|
| |
Director
|
Matt Sacks
|
| |
33
|
| |
Director
|
Sergey Sherman
|
| |
54
|
| |
Director
|
Mark Silver
|
| |
64
|
| |
Director
|
•
|
Class I, which consists of Matt Sacks and Mark Silver, whose terms will expire at SpringBig’s 2026 annual meeting of the
stockholders;
|
•
|
Class II, which consists of Shawn Dym, whose term will expire at SpringBig’s 2024 annual meeting of stockholders; and
|
•
|
Class III, which consists of Jeffrey Harris and Sergey Sherman, whose terms will expire at SpringBig’s 2025 annual meeting.
|
•
|
approve the hiring, discharging and compensation of SpringBig’s independent auditors;
|
•
|
oversee the work of SpringBig’s independent auditors;
|
•
|
approve engagements of the independent auditors to render any audit or permissible non-audit services;
|
•
|
review the qualifications, independence and performance of the independent auditors;
|
•
|
review SpringBig’s financial statements and review SpringBig’s critical accounting policies and estimates;
|
•
|
review the adequacy and effectiveness of SpringBig’s internal controls; and
|
•
|
review and discuss with management and the independent auditors the results of SpringBig’s annual audit, SpringBig’s
quarterly financial statements and SpringBig’s publicly filed reports.
|
•
|
Jeffrey Harris, SpringBig’s Chief Executive Officer;
|
•
|
Paul Sykes, SpringBig’s Chief Financial Officer; and
|
•
|
Navin Anand, SpringBig’s Former Chief Technology Officer.
|
Name and Principal Position
|
| |
Year
|
| |
Salary
($)
|
| |
Bonus
($)(2)
|
| |
Stock
Awards
($)(3)
|
| |
Option
Awards
($)
|
| |
Non-Equity
Incentive Plan
Compensation
($)
|
| |
All Other
Compensation
($)
|
| |
Total
($)
|
Jeffrey Harris
Chief Executive Officer
|
| |
2023
|
| |
$450,000
|
| |
$—
|
| |
$254,800
|
| |
$—
|
| |
$—
|
| |
$—
|
| |
$704,800
|
|
2022
|
| |
$371,731
|
| |
$609,375
|
| |
$—
|
| |
$—
|
| |
$—
|
| |
$—
|
| |
$981,106
|
||
Paul Sykes
Chief Financial Officer
|
| |
2023
|
| |
$350,000
|
| |
$—
|
| |
$105,350
|
| |
$—
|
| |
$—
|
| |
$—
|
| |
$455,350
|
|
2022
|
| |
$324,615
|
| |
$425,000
|
| |
$88,650
|
| |
$—
|
| |
$—
|
| |
$—
|
| |
$838,265
|
||
Navin Anand
Former Chief Technology Officer(1)
|
| |
2023
|
| |
$235,577
|
| |
$—
|
| |
$29,400
|
| |
$—
|
| |
$—
|
| |
$—
|
| |
$264,977
|
|
2022
|
| |
$228,116
|
| |
$60,000
|
| |
$88,650
|
| |
$—
|
| |
$—
|
| |
$—
|
| |
$376,766
|
(1)
|
Mr. Anand’s employment as Chief Technology Officer ceased effective December 8, 2023.
|
(2)
|
The amount reported in this column for Mr. Harris consists of (i) $300,000 paid in connection with the closing of the business
combination and (ii) $309,375 in aggregate grant date fair value of restricted stock granted in connection with the performance of the Company during 2022 pursuant to the Executive Employment Agreement, dated November 8, 2021 by and
between SpringBig and Mr. Harris. The aggregate number of shares underlying such restricted stock award was 300,000. The amount reported in this column for Mr. Sykes consists of (i) $250,000 paid in connection with the closing of the
business combination and (ii) $175,000 paid in connection with the performance of the Company during 2022 pursuant to the Executive Employment Agreement, dated November 8, 2021 by and between SpringBig and Mr. Sykes.
|
(3)
|
Amounts represent the aggregate grant date fair value of restricted stock granted to our named executive officers computed in
accordance with ASC Topic 718. The assumptions used in calculating the grant date fair value of the restricted stock units (“RSUs”) reported in this column are set forth in Note 16 — Stock Based Compensation to our consolidated
financial statements included elsewhere in this prospectus. These amounts do not reflect the actual economic value that may be realized by the named executive officer.
|
|
| |
|
| |
|
| |
|
| |
Option Awards
|
|||||||||
|
| |
Grant Date
|
| |
Vesting
Commencement
Date
|
| |
|
| |
Number of
securities
underlying
unexercised
options
(#) exercisable
|
| |
Number of
securities
underlying
unexercised
options
(#) unexercisable
|
| |
Option
exercise
price
($)
|
| |
Option
expiration
date
|
Jeffrey Harris
|
| |
3/17/2019
|
| |
3/17/2021
|
| |
(1)
|
| |
191,254
|
| |
|
| |
$0.52
|
| |
3/17/2029
|
|
| |
12/2/2020
|
| |
12/2/2021
|
| |
(1)
|
| |
74,111
|
| |
|
| |
$1.26
|
| |
12/2/2030
|
Paul Sykes
|
| |
6/21/2021
|
| |
4/7/2021
|
| |
(2)
|
| |
111,167
|
| |
|
| |
$1.26
|
| |
6/21/2031
|
Navin Anand(3)
|
| |
6/21/2021
|
| |
4/12/2021
|
| |
(2)
|
| |
101,903
|
| |
|
| |
$1.26
|
| |
6/21/2031
|
(1)
|
Represents an option vesting fully as of the closing of the business combination on June 14, 2022.
|
(2)
|
Represents an option vesting with respect to (a) 35% of the shares subject to the option on December 31, 2021, (b) 15% of the
shares subject to the option as of the closing of the business combination and (c) 50% of the shares subject to the option ratably over 24 months following the business combination.
|
(3)
|
Mr. Anand’s employment as Chief Technology Officer ceased effective December 8, 2023.
|
|
| |
|
| |
|
| |
Stock Awards
|
|||
|
| |
Grant Date
|
| |
|
| |
Number of
shares or units
of stock
that have not
(#) vested
|
| |
Market value of
shares or units of stock
that have not
($) vested(1)
|
Jeffrey Harris
|
| |
6/28/2023
|
| |
(2)
|
| |
820,000
|
| |
122,180
|
Paul Sykes
|
| |
7/7/2022
|
| |
(2)
|
| |
30,000
|
| |
4,470
|
Paul Sykes
|
| |
6/28/2023
|
| |
(2)
|
| |
215,000
|
| |
32,035
|
Navin Anand(3)
|
| |
7/7/2022
|
| |
(2)
|
| |
30,000
|
| |
4,470
|
Navin Anand(3)
|
| |
6/28/2023
|
| |
(2)
|
| |
60,000
|
| |
8,940
|
(1)
|
The amounts in this column are determined by multiplying (i) the number of RSUs shown in the previous column by (ii) $0.149
(the closing price of the Company’s common stock on December 31, 2023).
|
(2)
|
Restricted stock units vest one-third per year beginning on the first anniversary of the date of grant.
|
(3)
|
Mr. Anand’s employment as Chief Technology Officer ceased effective December 8, 2023.
|
Name
|
| |
Fees Earned or
Paid in Cash(1)
|
| |
Restricted
Stock Awards(2)(3)
|
| |
Total
|
Steven Bernstein(4)
|
| |
$22,000
|
| |
$12,250
|
| |
$34,250
|
Patricia Glassford(5)
|
| |
$23,000
|
| |
$12,250
|
| |
$35,250
|
Amanda Lannert(6)
|
| |
$21,875
|
| |
$12,250
|
| |
$34,125
|
Phil Schwarz(7)
|
| |
$21,000
|
| |
$12,250
|
| |
$33,250
|
Sergey Sherman(8)
|
| |
$20,250
|
| |
$12,250
|
| |
$32,500
|
Jon Trauben(9)
|
| |
$19,625
|
| |
$12,250
|
| |
$31,875
|
(1)
|
Includes annual fees paid to all directors for their service on the Board.
|
(2)
|
Amounts reported represent the aggregate grant date fair value of RSUs granted to such non-executive director during 2023
under the 2022 Plan, computed in accordance with ASC Topic 718. The assumptions used in calculating the grant date fair value of the RSUs reported in this column are set forth in Note 16 — Stock Based
Compensation to our consolidated financial statements included elsewhere in this prospectus. This amount does not reflect the actual economic value that may be realized by the director.
|
(3)
|
For each non-employee director who received restricted stock awards, the aggregate number of shares underlying such stock
award was 25,000.
|
(4)
|
Steven Bernstein resigned from the Board on August 31, 2023.
|
(5)
|
Patricia Glassford resigned from the Board on August 31, 2023.
|
(6)
|
Amanda Lennert resigned from the Board on August 30, 2023.
|
(7)
|
Phil Schwarz resigned from the Board on January 23, 2024.
|
(8)
|
All cash compensation received by Mr. Sherman has been paid to Tuatara Capital, L.P., where he serves as Managing Director —
Investments. All restricted stock awarded to Mr. Sherman as compensation for his service on the Board is held for the benefit of Tuatara Capital, L.P., and Mr. Sherman has no voting or investment power over such stock.
|
(9)
|
All cash compensation received by Mr. Trauben has been paid to Altitude Investment Management, where he serves as Partner. Mr.
Trauben resigned from the Board on January 23, 2024.
|
Name
|
| |
Convertible
Notes
Purchased ($)
|
| |
Term Notes
Purchased ($)
|
| |
Total ($)
|
Jeffrey Harris, Chief Executive Officer and Chairman
|
| |
320,000
|
| |
80,000
|
| |
400,000
|
Paul Sykes, Chief Financial Officer
|
| |
25,000
|
| |
6,250
|
| |
31,250
|
Jon Trauben, Director(1)
|
| |
15,000
|
| |
3,750
|
| |
18,750
|
(1)
|
Mr. Trauben resigned from the Board effective at 12 noon ET on the Notes Closing Date.
|
•
|
Voting and Support Agreements. In connection with the signing of the merger
agreement, on November 8, 2021, Tuatara, Legacy SpringBig and certain stockholders and optionholders of Legacy SpringBig and Tuatara entered into voting and support agreements, pursuant to which such Legacy SpringBig stockholders agreed
to vote all of their shares in Legacy SpringBig in favor of the merger agreement and related transactions and to take certain other actions in support of the merger agreement and related transactions. The Legacy SpringBig voting and
support members also each agreed, with certain exceptions, to a lock-up for a period of 180 days after the closing with respect to any securities of the Company that they receive as merger consideration under the merger agreement.
|
•
|
Subscription Agreements. Certain investors entered in subscription agreements
pursuant to which Tuatara agreed to issue and sell to the subscription investors, in the aggregate, $13,100,000 of common stock of Tuatara at a purchase price of $10.00 per share. The closing of the PIPE Subscription Financing occurred
immediately prior to the closing of the merger. Certain of the subscription investors that were existing stockholders of Legacy SpringBig entered into convertible notes with Legacy SpringBig for an aggregate principal sum of $7,000,000
(the “convertible notes”), which was funded on or around February 25, 2022. Those notes matured at the closing of the business combination and the holders received the shares they subscribed for under the subscription agreement, as well
as interest payments in the form of 31,356 shares of the Company.
|
•
|
Amended and Restated Registration Rights Agreement. In connection with the
consummation of the merger agreement and the business combination, on June 14, 2022, SpringBig and certain holders entered in an amended and restated registration rights agreement, pursuant to which such holders are able to make a
written demand for registration under the Securities Act of all or a portion of their registrable securities, subject to a maximum of three (3) such demand registrations for our sponsor and four (4) such demand registrations for the
other investors thereto, in each case so long as such demand includes a number of registrable securities with a total offering price in excess of $10 million. Any such demand may be in the form of an underwritten offering, it being
understood that we will not be able to conduct more than two underwritten offerings where the expected aggregate proceeds are less than $25 million but in excess of $10 million in any 12-month period.
|
•
|
Sponsor Escrow Agreement. The Sponsor, Tuatara and certain independent members of
the pre-business combination board of directors entered into an escrow agreement (“Sponsor Escrow Agreement”) at the closing of the business combination pursuant to which the Sponsor and certain members of the pre-business combination
board of directors deposited an aggregate of 1,000,000 shares of the Company’s Common Stock (“Sponsor Earnout Shares”) into escrow. The Sponsor Escrow Agreement provides that such Sponsor Earnout Shares will either be released to the
Sponsor if the closing price of the Company’s Common Stock equals or exceeds $12.00 per share (as adjusted for share splits, share dividends, reorganizations, and recapitalizations) on any twenty (20) trading days in a thirty
(30)-trading-day period at any time after the closing date and by the fifth anniversary of the closing date. The Sponsor Earnout Shares will be terminated and canceled by the Company if such condition is not met at any time after the
closing date and by the fifth anniversary of the closing date.
|
•
|
each person known by the Company to be the beneficial owner of more than 5% of outstanding Common Shares;
|
•
|
each of the Company’s named executive officers and directors; and
|
•
|
all executive officers and directors of the Company as a group.
|
Name of Beneficial Owner
|
| |
Number of Shares
of Common Stock
Beneficially
Owned
|
| |
Percentage of
Outstanding
Common Stock
|
5% Stockholders
|
| |
|
| |
|
Medici Holdings V, Inc.
|
| |
4,743,120
|
| |
10.9
|
Tuatara Capital Fund II, L.P.(1)
|
| |
4,470,000
|
| |
10.3
|
|
| |
|
| |
|
Executive Officer and Directors of the Company
|
| |
|
| |
|
Jeffrey Harris(2)
|
| |
8,094,090
|
| |
17.4
|
Paul Sykes(3)
|
| |
687,016
|
| |
1.6
|
Shawn Dym
|
| |
—
|
| |
*
|
Matt Sacks
|
| |
—
|
| |
*
|
Sergey Sherman
|
| |
—
|
| |
*
|
Mark Silver
|
| |
—
|
| |
*
|
All directors and named executive officers of SpringBig as
a group (5 individuals):
|
| |
8,781,106
|
| |
19.1
|
*
|
Represents beneficial ownership of less than 1% of the outstanding shares of our common stock.
|
(1)
|
Includes 3,870,000 shares of common stock held by the Sponsor and 600,000 shares of common stock held by Tuatara Capital Fund
II, L.P. Tuatara Capital Fund II, L.P. (“Fund II”) is the sole member of TCAC Sponsor, LLC. Accordingly, shares of common stock held by TCAC Sponsor, LLC may be attributed to Fund II. Fund II is controlled by a board of managers
comprised of three individuals - Albert Foreman, Mark Zittman and Marc Riiska. Any action by our sponsor with respect to our company or the founders’ shares, including voting and dispositive decisions, requires a majority vote of the
managers of the board of managers of Fund II. Under the so-called “rule of three,” because voting and dispositive decisions are made by a majority of Fund II’s managers, none of the managers is deemed to be a beneficial owner of our
sponsor’s securities, even those in which he holds a pecuniary interest. Accordingly, none of the managers is deemed to have or share beneficial ownership of the founders’ shares held by the Sponsor.
|
(2)
|
Includes (i) the shares of common stock held by Medici Holdings V, Inc., an estate planning vehicle through which Mr. Harris
shares ownership with family members of Mr. Harris and for which Mr. Harris may be deemed to have investment discretion and voting power, (ii) 265,365 shares of Common Stock underlying fully vested stock options that are exercisable for
shares of common stock within 60 days and (iii) 2,133,333 shares of Common Stock issuable upon conversion of the Convertible Notes.
|
(3)
|
Includes 166,666 shares of Common Stock issuable upon conversion of the Convertible Notes.
|
|
| |
Securities Beneficially
Owned
Prior to this Offering
|
| |
|
| |
Securities to be
Registered
in this Offering(1)
|
| |
|
| |
Securities to be Beneficially
Owned After this Offering
|
|||||||||
Name of Selling Securityholder
|
| |
Common
Stock(2)
|
| |
Warrants(3)
|
| |
Common
Stock(2)
|
| |
Warrants(3)
|
| |
Common
Stock(2)
|
| |
%
|
| |
Warrants(3)
|
| |
%
|
Tuatara Capital Fund II, L.P.(4)
|
| |
4,470,000
|
| |
6,000,000
|
| |
4,470,000
|
| |
6,000,000
|
| |
—
|
| |
—
|
| |
—
|
| |
—
|
Michael Finkelman
|
| |
40,000
|
| |
—
|
| |
15,000
|
| |
—
|
| |
—
|
| |
—
|
| |
—
|
| |
—
|
Key Investment Partners Fund I LP(5)
|
| |
344,885
|
| |
—
|
| |
135,926
|
| |
—
|
| |
—
|
| |
—
|
| |
—
|
| |
—
|
KP Capital LLC
|
| |
779,404
|
| |
—
|
| |
779,404
|
| |
—
|
| |
—
|
| |
—
|
| |
—
|
| |
—
|
Jeffrey Harris(5)
|
| |
8,094,090
|
| |
—
|
| |
8,094,090
|
| |
—
|
| |
—
|
| |
—
|
| |
—
|
| |
—
|
Medici Holdings V, Inc.
|
| |
4,743,120
|
| |
—
|
| |
4,743,120
|
| |
—
|
| |
—
|
| |
—
|
| |
—
|
| |
—
|
ABG, LLC
|
| |
518,275
|
| |
—
|
| |
518,275
|
| |
—
|
| |
—
|
| |
—
|
| |
—
|
| |
—
|
Argonautic Ventures Master SPC
|
| |
844,229
|
| |
—
|
| |
844,229
|
| |
—
|
| |
—
|
| |
—
|
| |
—
|
| |
—
|
Argonautic Vertical Series SpringBig Fund I SP
|
| |
62,644
|
| |
—
|
| |
62,644
|
| |
—
|
| |
—
|
| |
—
|
| |
—
|
| |
—
|
Paul Sykes(6)
|
| |
687,016
|
| |
—
|
| |
687,016
|
| |
—
|
| |
—
|
| |
—
|
| |
—
|
| |
—
|
Salex Capital, LLC
|
| |
552,060
|
| |
—
|
| |
552,060
|
| |
—
|
| |
—
|
| |
—
|
| |
—
|
| |
—
|
Manja Lyssy Revocable Trust
|
| |
879,007
|
| |
—
|
| |
879,007
|
| |
—
|
| |
—
|
| |
—
|
| |
—
|
| |
—
|
Halley Venture Fund I LP(7)
|
| |
1,019,274
|
| |
—
|
| |
1,019,274
|
| |
—
|
| |
—
|
| |
—
|
| |
—
|
| |
—
|
Halley Venture Fund II LP(7)
|
| |
870,918
|
| |
—
|
| |
870,918
|
| |
—
|
| |
—
|
| |
—
|
| |
—
|
| |
—
|
Altitude Investment Partners, LP
|
| |
1,528,295
|
| |
—
|
| |
1,528,295
|
| |
—
|
| |
—
|
| |
—
|
| |
—
|
| |
—
|
Soctech Israel, LLC
|
| |
473,093
|
| |
—
|
| |
473,093
|
| |
—
|
| |
—
|
| |
—
|
| |
—
|
| |
—
|
Gamson Family Revocable Trust
|
| |
1,306,326
|
| |
—
|
| |
1,306,326
|
| |
—
|
| |
—
|
| |
—
|
| |
—
|
| |
—
|
Green Acre Capital Fund I LP
|
| |
967,757
|
| |
—
|
| |
967,757
|
| |
—
|
| |
—
|
| |
—
|
| |
—
|
| |
—
|
TVC Capital IV, L.P.
|
| |
2,495,499
|
| |
—
|
| |
2,495,499
|
| |
—
|
| |
—
|
| |
—
|
| |
—
|
| |
—
|
Michael Faber
|
| |
286,250
|
| |
—
|
| |
286,250
|
| |
—
|
| |
—
|
| |
—
|
| |
—
|
| |
—
|
|
| |
Securities Beneficially
Owned
Prior to this Offering
|
| |
|
| |
Securities to be
Registered
in this Offering(1)
|
| |
|
| |
Securities to be Beneficially
Owned After this Offering
|
|||||||||
Name of Selling Securityholder
|
| |
Common
Stock(2)
|
| |
Warrants(3)
|
| |
Common
Stock(2)
|
| |
Warrants(3)
|
| |
Common
Stock(2)
|
| |
%
|
| |
Warrants(3)
|
| |
%
|
Douglas J. Stukel
|
| |
150,000
|
| |
—
|
| |
150,000
|
| |
—
|
| |
—
|
| |
—
|
| |
—
|
| |
—
|
Michael A. Gross
|
| |
1,275,000
|
| |
—
|
| |
1,275,000
|
| |
—
|
| |
—
|
| |
—
|
| |
—
|
| |
—
|
Jason Wright
|
| |
425,000
|
| |
—
|
| |
425,000
|
| |
—
|
| |
—
|
| |
—
|
| |
—
|
| |
—
|
Shalcor Management Inc.(9)
|
| |
18,666,666
|
| |
—
|
| |
18,666,666
|
| |
—
|
| |
—
|
| |
—
|
| |
—
|
| |
—
|
Lightbank II, L.P.(10)
|
| |
16,000,000
|
| |
—
|
| |
16,000,000
|
| |
—
|
| |
—
|
| |
—
|
| |
—
|
| |
—
|
Balkin Family Investments, LLC(11)
|
| |
1,000,000
|
| |
—
|
| |
1,000,000
|
| |
—
|
| |
—
|
| |
—
|
| |
—
|
| |
—
|
Bob Feig(11)
|
| |
1,000,000
|
| |
—
|
| |
1,000,000
|
| |
—
|
| |
—
|
| |
—
|
| |
—
|
| |
—
|
MWAD Alt Investments LLC(11)
|
| |
800,000
|
| |
—
|
| |
800,000
|
| |
—
|
| |
—
|
| |
—
|
| |
—
|
| |
—
|
Gilad Ottensoser(11)
|
| |
600,000
|
| |
—
|
| |
600,000
|
| |
—
|
| |
—
|
| |
—
|
| |
—
|
| |
—
|
CR Financial Holdings, Inc.(11)
|
| |
500,000
|
| |
—
|
| |
500,000
|
| |
—
|
| |
—
|
| |
—
|
| |
—
|
| |
—
|
Wayland Investments, LLC(11)
|
| |
500,000
|
| |
—
|
| |
500,000
|
| |
—
|
| |
—
|
| |
—
|
| |
—
|
| |
—
|
Jeff Rosenberg(11)
|
| |
200,000
|
| |
—
|
| |
200,000
|
| |
—
|
| |
—
|
| |
—
|
| |
—
|
| |
—
|
Jon Trauben(11)
|
| |
100,000
|
| |
—
|
| |
100,000
|
| |
—
|
| |
—
|
| |
—
|
| |
—
|
| |
—
|
(1)
|
The amounts set forth in this column are the number of Common Stock and private placement warrants that may be offered for
sale from time to time by each Selling Securityholder using this prospectus. These amounts do not represent any other shares of our Common Stock or warrants that the Selling Securityholder may own beneficially or otherwise.
|
(2)
|
Represents our Common Stock, including Common Stock underlying options, as applicable.
|
(3)
|
Represents the private placement warrants.
|
(4)
|
Includes 3,870,000 shares of Common Stock held by TCAC Sponsor, LLC and 600,000 PIPE shares held by Tuatara Capital Fund II,
L.P. Tuatara Capital Fund II, L.P. (“Fund II”) is the sole member of TCAC Sponsor, LLC. Accordingly, shares of Common Stock held by TCAC Sponsor, LLC may be attributed to Fund II. Fund II is controlled by a board of managers comprised
of three individuals - Albert Foreman, Mark Zittman and Marc Riiska. Any action by our sponsor with respect to our company or the founders’ shares, including voting and dispositive decisions, requires a majority vote of the managers of
the board of managers of Fund II. Under the so-called “rule of three,” because voting and dispositive decisions are made by a majority of Fund II’s managers, none of the managers is deemed to be a beneficial owner of our sponsor’s
securities, even those in which he holds a pecuniary interest. Accordingly, none of the managers is deemed to have or share beneficial ownership of the founders’ shares held by the Sponsor.
|
(5)
|
Includes 208,959 PIPE shares and 2,133,333 Conversion Shares. Excludes the shares of Common Stock held by Medici Holdings V,
Inc., an estate planning vehicle through which Mr. Harris shares ownership with family members of Mr. Harris and for which Mr. Harris may be deemed to have investment discretion and voting power. Includes 10,000 PIPE shares.
|
(6)
|
Includes 166,666 Conversion Shares.
|
(7)
|
Includes 200,000 Conversion Shares.
|
(8)
|
Includes 800,000 Conversion Shares.
|
(9)
|
Represents Conversion Shares. Mark L. Silver is the President of Shalcor and Shawn Dym is the Managing Director of Shalcor and
as such each could be deemed to share voting control and investment power over shares that may be deemed to be beneficially owned by Shalcor, but disclaims beneficial ownership of such shares except to the extent of his pecuniary
interest therein. In connection with the Nomination Agreement, Mr. Dym and Mr. Silver joined the board of directors of the Company on January 23, 2024 and May 10, 2024, respectively.
|
(10)
|
Includes 16,000,000 Conversion Shares. The Convertible Notes in the principal amount of $2.4 million and the 12% Senior
Secured Term Promissory Notes due 2026 in the principal amount of $600,000 are held for the account of Lightbank II, L.P. (“Lightbank II”), an investment fund managed by Lightbank Asset Management, LLC (“LAM”). Eric Lefkofsky is the
Co-Managing Partner of LAM. As a result, each of LAM and Mr. Lefkofsky share voting and investment control over the securities held for the account of Lightbank II. In addition, on January 23, 2024, Lightbank II entered into the
Nomination Agreement with the Company and Shalcor Management, Inc. In connection with the Nomination Agreement, Matt Sacks, the Co-Managing Partner of Lightbank II, joined the board of directors of the Company on January 23, 2024.
|
(11)
|
Represents Conversion Shares.
|
•
|
in whole and not in part;
|
•
|
at a price of $0.01 per public warrant;
|
•
|
upon not less than thirty (30) days’ prior written notice of redemption to each public warrant holder; and
|
•
|
if, and only if, the reported last sales price of the shares of common stock equals or exceeds $18.00 per share (as adjusted
for share splits, share dividends, rights issuances, subdivisions, reorganizations, recapitalizations and the like) for any 20 trading days within a 30-trading day period ending on the third trading day prior to the date SpringBig sends
the notice of redemption to the public warrant holders (the “Reference Value”).
|
•
|
in whole and not in part;
|
•
|
at $0.10 per warrant upon a minimum of 30 days’ prior written notice of redemption, provided that holders will be able to
exercise their warrants on a cashless basis prior to redemption based on the redemption date and the “fair market value” of our Common Shares;
|
•
|
if, and only if, the Reference Value equals or exceeds $10.00 per share (as adjusted for adjustments to the number of shares
issuable upon exercise or the exercise price of a warrant); and
|
•
|
if the Reference Value is less than $18.00 per share (as adjusted for adjustments to the number of shares issuable upon
exercise or the exercise price of a warrant), the private placement warrants must also concurrently be called for redemption on the same terms as the outstanding public warrants.
|
|
| |
Fair Market Value of Shares of Common Stock
|
||||||||||||||||||||||||
Redemption Date
(period to expiration of warrants)
|
| |
$10.00
|
| |
$11.00
|
| |
$12.00
|
| |
$13.00
|
| |
$14.00
|
| |
$15.00
|
| |
$16.00
|
| |
$17.00
|
| |
$18.00
|
60 months
|
| |
0.261
|
| |
0.281
|
| |
0.297
|
| |
0.311
|
| |
0.324
|
| |
0.337
|
| |
0.348
|
| |
0.358
|
| |
0.361
|
57 months
|
| |
0.257
|
| |
0.277
|
| |
0.294
|
| |
0.31
|
| |
0.324
|
| |
0.337
|
| |
0.348
|
| |
0.358
|
| |
0.361
|
54 months
|
| |
0.252
|
| |
0.272
|
| |
0.291
|
| |
0.307
|
| |
0.322
|
| |
0.335
|
| |
0.347
|
| |
0.357
|
| |
0.361
|
51 months
|
| |
0.246
|
| |
0.268
|
| |
0.287
|
| |
0.304
|
| |
0.32
|
| |
0.333
|
| |
0.346
|
| |
0.357
|
| |
0.361
|
48 months
|
| |
0.241
|
| |
0.263
|
| |
0.283
|
| |
0.301
|
| |
0.317
|
| |
0.332
|
| |
0.344
|
| |
0.356
|
| |
0.361
|
45 months
|
| |
0.235
|
| |
0.258
|
| |
0.279
|
| |
0.298
|
| |
0.315
|
| |
0.33
|
| |
0.343
|
| |
0.356
|
| |
0.361
|
42 months
|
| |
0.228
|
| |
0.252
|
| |
0.274
|
| |
0.294
|
| |
0.312
|
| |
0.328
|
| |
0.342
|
| |
0.355
|
| |
0.361
|
39 months
|
| |
0.221
|
| |
0.246
|
| |
0.269
|
| |
0.29
|
| |
0.309
|
| |
0.325
|
| |
0.34
|
| |
0.354
|
| |
0.361
|
36 months
|
| |
0.213
|
| |
0.239
|
| |
0.263
|
| |
0.285
|
| |
0.305
|
| |
0.323
|
| |
0.339
|
| |
0.353
|
| |
0.361
|
33 months
|
| |
0.205
|
| |
0.232
|
| |
0.257
|
| |
0.28
|
| |
0.301
|
| |
0.32
|
| |
0.337
|
| |
0.352
|
| |
0.361
|
30 months
|
| |
0.196
|
| |
0.224
|
| |
0.25
|
| |
0.274
|
| |
0.297
|
| |
0.316
|
| |
0.335
|
| |
0.351
|
| |
0.361
|
27 months
|
| |
0.185
|
| |
0.214
|
| |
0.242
|
| |
0.268
|
| |
0.291
|
| |
0.313
|
| |
0.332
|
| |
0.35
|
| |
0.361
|
24 months
|
| |
0.173
|
| |
0.204
|
| |
0.233
|
| |
0.26
|
| |
0.285
|
| |
0.308
|
| |
0.329
|
| |
0.348
|
| |
0.361
|
21 months
|
| |
0.161
|
| |
0.193
|
| |
0.223
|
| |
0.252
|
| |
0.279
|
| |
0.304
|
| |
0.326
|
| |
0.347
|
| |
0.361
|
18 months
|
| |
0.146
|
| |
0.179
|
| |
0.211
|
| |
0.242
|
| |
0.271
|
| |
0.298
|
| |
0.322
|
| |
0.345
|
| |
0.361
|
15 months
|
| |
0.13
|
| |
0.164
|
| |
0.197
|
| |
0.23
|
| |
0.262
|
| |
0.291
|
| |
0.317
|
| |
0.342
|
| |
0.361
|
12 months
|
| |
0.111
|
| |
0.146
|
| |
0.181
|
| |
0.216
|
| |
0.25
|
| |
0.282
|
| |
0.312
|
| |
0.339
|
| |
0.361
|
9 months
|
| |
0.09
|
| |
0.125
|
| |
0.162
|
| |
0.199
|
| |
0.237
|
| |
0.272
|
| |
0.305
|
| |
0.336
|
| |
0.361
|
6 months
|
| |
0.065
|
| |
0.099
|
| |
0.137
|
| |
0.178
|
| |
0.219
|
| |
0.259
|
| |
0.296
|
| |
0.331
|
| |
0.361
|
3 months
|
| |
0.034
|
| |
0.065
|
| |
0.104
|
| |
0.15
|
| |
0.197
|
| |
0.243
|
| |
0.286
|
| |
0.326
|
| |
0.361
|
0 months
|
| |
—
|
| |
—
|
| |
0.042
|
| |
0.115
|
| |
0.179
|
| |
0.233
|
| |
0.281
|
| |
0.323
|
| |
0.361
|
(i)
|
If the Earnout Trigger Event occurs prior to the one-year anniversary of the Effective Time and results in an Earnout Trigger
Price that is greater than $10.00, but less than $12.00, then only a portion of the First Tranche Shares shall be issued to the Legacy SpringBig shareholders and Engaged Option Holders equal to the First Tranche Shares multiplied by a
fraction calculated as: (A) the numerator of which shall be the Earnout Trigger Price minus $10 and (B) the denominator of which is 2.
|
(ii)
|
If the Earnout Trigger Event occurs after the one-year anniversary of the Closing Date and results in an Earnout Trigger
Price that is less than $12.00, then none of the Contingent Shares shall be issued.
|
(iii)
|
If the Earnout Trigger Event occurs at any time during the 60 months following the effective time and results in an Earnout
Trigger Price that is equal to or greater than $15.00, but less than $18.00, then only the First Tranche Shares and Second Tranche Shares shall be issued to the Legacy SpringBig shareholders and Engaged Option Holders.
|
(iv)
|
If the Earnout Trigger Event occurs at any time during the 60 months following the effective time and results in an Earnout
Trigger Price equal to or greater than $18.00, then all of the Contingent Shares shall be issued to the Legacy SpringBig shareholders and Engaged Option Holders.
|
•
|
A shareholder who owns fifteen percent or more of SpringBig’s outstanding voting stock (otherwise known as an “interested
shareholder”);
|
•
|
an affiliate of an interested shareholder; or
|
•
|
an associate of an interested shareholder, for three (3) years following the date that the shareholder became an interested
shareholder.
|
•
|
SpringBig’s Board of Directors approves the transaction that made the shareholder an “interested shareholder,” prior to the
date of the transaction;
|
•
|
after the completion of the transaction that resulted in the shareholder becoming an interested shareholder, that shareholder
owned at least 85% of SpringBig’s voting stock outstanding at the time the transaction commenced, other than statutorily excluded shares of common stock; or
|
•
|
on or subsequent to the date of the transaction, the business combination is approved by SpringBig’s Board of Directors and
authorized at a meeting of SpringBig’s shareholders, and not by written consent, by an affirmative vote of at least two-thirds of the outstanding voting stock not owned by the interested shareholder.
|
•
|
financial institutions or financial services entities;
|
•
|
insurance companies;
|
•
|
mutual funds;
|
•
|
qualified plans, such as 401(k) plans, individual retirement accounts, etc.;
|
•
|
persons that actually or constructively own five percent or more (by vote or value) of the outstanding Common Stock;
|
•
|
persons that acquired our securities pursuant to an exercise of employee share options, in connection with employee share
incentive plans or otherwise as compensation;
|
•
|
broker-dealers;
|
•
|
persons that are subject to the mark-to-market accounting rules;
|
•
|
persons holding securities as part of a “straddle,” hedge, integrated transaction or similar transaction;
|
•
|
U.S. Holders (as defined below) whose functional currency is not the U.S. dollar;
|
•
|
partnerships or other pass-through entities for U.S. federal income tax purposes and any beneficial owners of such entities;
|
•
|
regulated investment companies or real estate investment trusts; certain expatriates or former long-term residents of the
U.S.;
|
•
|
governments or agencies or instrumentalities thereof;
|
•
|
U.S. expatriates of former long-term residents of the U.S.;
|
•
|
controlled foreign corporations and passive foreign investment companies;
|
•
|
tax-exempt entities;
|
•
|
persons required to accelerate the recognition of any item of gross income with respect to securities as a result of such
income being recognized on an applicable financial statement; or
|
•
|
the Sponsor or its affiliates.
|
•
|
an individual who is a citizen or resident of the U.S.;
|
•
|
a corporation (or other entity treated as a corporation for U.S. federal income tax purposes) organized in or under the laws
of the U.S., any state thereof or the District of Columbia;
|
•
|
an estate whose income of which is includible in gross income for U.S. federal income tax purposes regardless of its source;
or
|
•
|
a trust if (i) a U.S. court can exercise primary supervision over the trust’s administration and one or more United States
persons (as defined in the Code) are authorized to control all substantial decisions of the trust, or (ii) it has a valid election in effect under applicable U.S. Treasury Regulations to be treated as a United States person.
|
•
|
the gain is effectively connected with the conduct of a trade or business by the non-U.S. Holder within the United States
(and, if an applicable tax treaty so requires, is attributable to a U.S. permanent establishment or fixed base maintained by the non-U.S. Holder);
|
•
|
the non-U.S. Holder is an individual who is present in the United States for 183 days or more in the taxable year of
disposition and certain other conditions are met; or
|
•
|
we are or have been a “United States real property holding corporation” (“USRPHC”) for U.S. federal income tax purposes at
any time during the shorter of the five-year period ending on the date of disposition or the period that the non-U.S. Holder held our Common Stock, and, in the case where shares of our Common Stock are regularly traded on an established
securities market, the non-U.S. Holder has owned, directly or constructively, more than 5% of our Common Stock at any time within the shorter of the five-year period preceding the disposition or such non-U.S. Holder’s holding period for
the shares of our Common Stock. There can be no assurance that our Common Stock will be treated as regularly traded on an established securities market for this purpose.
|
•
|
purchases by a broker-dealer as principal and resale by such broker-dealer for its own account pursuant to this prospectus;
|
•
|
ordinary brokerage transactions and transactions in which the broker solicits purchasers;
|
•
|
block trades in which the broker-dealer so engaged will attempt to sell the securities as agent but may position and resell a
portion of the block as principal to facilitate the transaction;
|
•
|
through trading plans entered into by a Selling Securityholder pursuant to Rule 10b5-1 under the Exchange Act that are in
place at the time of an offering pursuant to this prospectus and any applicable prospectus supplement hereto that provide for periodic sales of their securities on the basis of parameters described in such trading plans;
|
•
|
through one or more underwritten offerings on a firm commitment or best efforts basis;
|
•
|
settlement of short sales entered into after the date of this prospectus;
|
•
|
agreements with broker-dealers to sell a specified number of the securities at a stipulated price per share or warrant;
|
•
|
in at the market offerings, as defined in Rule 415 under the Securities Act, at negotiated prices, at prices prevailing at
the time of sale or at prices related to such prevailing market prices, including sales made directly on a national securities exchange or sales made through a market maker other than on an exchange or other similar offerings through
sales agents;
|
•
|
directly to purchasers, including through a specific bidding, auction or other process or in privately negotiated
transactions;
|
•
|
through the writing or settlement of options or other hedging transactions, whether through an options exchange or otherwise;
|
•
|
through the distribution of the securities by any Selling Securityholder to its partners, members or stockholders;
|
•
|
by pledge to secure debts and other obligations;
|
•
|
through a combination of any of the above methods of sale; or
|
•
|
any other method permitted pursuant to applicable law.
|
•
|
the specific securities to be offered and sold;
|
•
|
the names of the Selling Securityholders;
|
•
|
the respective purchase prices and public offering prices, the proceeds to be received from the sale, if any, and other
material terms of the offering;
|
•
|
settlement of short sales entered into after the date of this prospectus;
|
•
|
the names of any participating agents, broker-dealers or underwriters; and
|
•
|
any applicable commissions, discounts, concessions and other items constituting compensation from the selling
securityholders.
|
•
|
1% of the total number of Common Shares then outstanding; or
|
•
|
the average weekly reported trading volume of such securities during the four calendar weeks preceding the filing of a notice
on Form 144 with respect to the sale.
|
Unaudited Financial Statements
|
| |
|
| | ||
| | ||
| | ||
| | ||
| | ||
|
| |
|
Audited Financial Statements
|
| |
|
| | ||
| | ||
| | ||
| | ||
| | ||
| |
|
| |
March 31,
2024
|
| |
December 31,
2023
|
|
| |
(unaudited)
|
| |
(audited)
|
|
| |
(In thousands except share data)
|
|||
ASSETS
|
| |
|
| |
|
Assets
|
| |
|
| |
|
Current assets:
|
| |
|
| |
|
Cash and cash equivalents
|
| |
$
|
| |
$
|
Accounts receivable, net
|
| |
|
| |
|
Contract assets
|
| |
|
| |
|
Prepaid expenses and other current assets
|
| |
|
| |
|
Total current assets
|
| |
|
| |
|
Operating lease assets
|
| |
|
| |
|
Property and equipment, net
|
| |
|
| |
|
Total assets
|
| |
$
|
| |
$
|
|
| |
|
| |
|
LIABILITIES AND STOCKHOLDERS’ DEFICIT
|
| |
|
| |
|
Liabilities
|
| |
|
| |
|
Current liabilities:
|
| |
|
| |
|
Accounts payable
|
| |
$
|
| |
$
|
Accrued expense and other current liabilities
|
| |
|
| |
|
Short-term cash advances
|
| |
|
| |
|
Current maturities of long-term debt
|
| |
|
| |
|
Deferred payroll tax credits
|
| |
|
| |
|
Deferred revenue
|
| |
|
| |
|
Related party payable
|
| |
|
| |
|
Operating lease liability, current
|
| |
|
| |
|
Total current liabilities
|
| |
|
| |
|
Long-term debt, non-current
|
| |
|
| |
|
Operating lease liability, non-current
|
| |
|
| |
|
Warrant liabilities
|
| |
|
| |
|
Total liabilities
|
| |
$
|
| |
$
|
|
| |
|
| |
|
Commitments and Contingencies
|
| | | |
|
|
|
| |
|
| |
|
Stockholders’ Deficit
|
| |
|
| |
|
Common stock par value $
|
| |
|
| |
|
Additional paid-in-capital
|
| |
|
| |
|
Accumulated deficit
|
| |
(
|
| |
(
|
Total stockholders’ deficit
|
| |
$(
|
| |
$(
|
Total liabilities and stockholders’ deficit
|
| |
$
|
| |
$
|
|
| |
Three Months Ended March 31,
|
|||
|
| |
2024
|
| |
2023
|
|
| |
(In thousands, except share and per share data)
|
|||
Revenues
|
| |
$
|
| |
$
|
Cost of revenues
|
| |
|
| |
|
Gross profit
|
| |
|
| |
|
Operating expenses
|
| |
|
| |
|
Selling, servicing and marketing
|
| |
|
| |
|
Technology and software development
|
| |
|
| |
|
General and administrative
|
| |
|
| |
|
Total operating expenses
|
| |
|
| |
|
|
| |
|
| |
|
Loss from operations
|
| |
(
|
| |
(
|
Interest income
|
| |
|
| |
|
Interest expense
|
| |
(
|
| |
(
|
Gain on note repurchase
|
| |
|
| |
|
Change in fair value of warrants
|
| |
(
|
| |
(
|
Income (loss) before income tax
|
| |
|
| |
(
|
Income tax expense
|
| |
|
| |
|
Net income (loss)
|
| |
$
|
| |
$(
|
Net income (loss) per common share:
|
| |
|
| |
|
Basic
|
| |
$
|
| |
$(
|
Diluted
|
| |
$
|
| |
$(
|
|
| |
|
| |
|
Weighted-average common shares outstanding
|
| |
|
| |
|
Basic
|
| |
|
| |
|
Diluted
|
| |
|
| |
|
|
| |
Common Stock
|
| |
Additional Paid-in-
Capital
|
| |
Accumulated
Deficit
|
| |
Total
|
|||
|
| |
Shares
|
| |
Amount
|
| ||||||||
Balance at December 31, 2023
|
| |
|
| |
$
|
| |
$
|
| |
$(
|
| |
$(
|
Stock-based compensation
|
| |
—
|
| |
—
|
| |
|
| |
—
|
| |
|
Issuance of common stock*
|
| |
|
| |
—
|
| |
|
| |
—
|
| |
|
Net income
|
| |
—
|
| |
—
|
| |
—
|
| |
|
| |
|
Balance at March 31, 2024
|
| |
|
| |
$
|
| |
$
|
| |
$(
|
| |
$(
|
*
|
Common shares issued in exchange for services rendered.
|
|
| |
Common Stock
|
| |
Additional Paid-in-
Capital
|
| |
Accumulated
Deficit
|
| |
Total
|
|||
|
| |
Shares
|
| |
Amount
|
| ||||||||
Balance at December 31, 2022
|
| |
|
| |
$
|
| |
$
|
| |
$(
|
| |
$(
|
Stock-based compensation
|
| |
—
|
| |
—
|
| |
|
| |
—
|
| |
|
Exercise of stock options
|
| |
|
| |
—
|
| |
|
| |
—
|
| |
|
Net loss
|
| |
—
|
| |
—
|
| |
—
|
| |
(
|
| |
(
|
Balance at March 31, 2023
|
| |
|
| |
$
|
| |
$
|
| |
$(
|
| |
$(
|
|
| |
Three Months Ended March 31,
|
|||
|
| |
2024
|
| |
2023
|
|
| |
(In thousands)
|
|||
Cash flows from operating activities:
|
| |
|
| |
|
Net income (loss)
|
| |
$
|
| |
$(
|
Adjustments to reconcile net income (loss) to net cash
provided by (used in) operating activities:
|
| |
|
| |
|
Gain on note repurchase
|
| |
(
|
| |
|
Non-cash interest expense
|
| |
|
| |
|
Depreciation and amortization
|
| |
|
| |
|
Discount amortization on convertible note
|
| |
|
| |
|
Amortization of debt financing costs
|
| |
|
| |
|
Stock-based compensation
|
| |
|
| |
|
Bad debt expense
|
| |
|
| |
|
Accrued interest on convertible notes
|
| |
|
| |
|
Amortization of operating lease right of use assets
|
| |
|
| |
|
Change in fair value of warrants
|
| |
|
| |
|
Changes in operating assets and liabilities:
|
| |
|
| |
|
Accounts receivable
|
| |
(
|
| |
(
|
Prepaid expenses and other current assets
|
| |
|
| |
|
Contract assets
|
| |
|
| |
|
Accounts payable and other liabilities
|
| |
(
|
| |
|
Deferred payroll tax credits
|
| |
|
| |
|
Operating lease liabilities
|
| |
|
| |
(
|
Deferred revenue
|
| |
|
| |
(
|
Net cash provided by (used in) operating activities
|
| |
(
|
| |
|
|
| |
|
| |
|
Cash flows from investing activities:
|
| |
|
| |
|
Purchase of convertible note
|
| |
|
| |
(
|
Purchases of property and equipment
|
| |
(
|
| |
(
|
Net cash used in investing activities
|
| |
(
|
| |
(
|
|
| |
|
| |
|
Cash flows from financing activities:
|
| |
|
| |
|
Proceeds from issuance of convertible notes
|
| |
|
| |
|
Repayment of convertible notes
|
| |
(
|
| |
(
|
Proceeds from issuance of term notes
|
| |
|
| |
|
Repayment of short-term cash advance
|
| |
(
|
| |
|
Repayment of related party payable
|
| |
(
|
| |
|
Cost of convertible and term note issuance
|
| |
(
|
| |
|
Proceeds from exercise of stock options
|
| |
|
| |
|
Net cash provided by (used in) financing activities
|
| |
|
| |
(
|
|
| |
|
| |
|
Net increase (decrease) in cash and cash equivalents
|
| |
|
| |
$(
|
Cash and cash equivalents at beginning of period
|
| |
|
| |
|
Cash and cash equivalents at end of period
|
| |
$
|
| |
$
|
|
| |
|
| |
|
Supplemental cash flows disclosures
|
| |
|
| |
|
Interest paid
|
| |
$
|
| |
$
|
Common stock issued for services rendered relating to debt financing
|
| |
$
|
| |
$
|
Accrued cost of debt issuance
|
| |
$
|
| |
$
|
Obtaining a right-of-use asset in exchange for a lease liability
|
| |
$
|
| |
$
|
|
| |
March 31,
2024
|
| |
December 31,
2023
|
|
| |
(unaudited)
|
| |
(audited)
|
Accounts receivable
|
| |
$
|
| |
$
|
Unbilled receivables
|
| |
|
| |
|
Total receivables
|
| |
|
| |
|
Less allowance for doubtful accounts
|
| |
(
|
| |
(
|
Accounts receivable, net
|
| |
$
|
| |
$
|
|
| |
Allowance for credit losses
|
Outstanding Balance, December 31, 2023
|
| |
$
|
Current-period provision (release) for expected credit losses
|
| |
|
Write-offs charged against the allowance, net of recoveries and other
|
| |
|
Outstanding Balance, March 31, 2024
|
| |
$
|
|
| |
March 31,
2024
|
| |
December 31,
2023
|
|
| |
(unaudited)
|
| |
(audited)
|
Prepaid insurance
|
| |
$
|
| |
$
|
Other prepaid expenses
|
| |
|
| |
|
Deposits
|
| |
|
| |
|
|
| |
$
|
| |
$
|
|
| |
March 31,
2024
|
| |
December 31,
2023
|
|
| |
(unaudited)
|
| |
(audited)
|
Computer equipment
|
| |
$
|
| |
$
|
Furniture & fixtures
|
| |
|
| |
|
Data warehouse
|
| |
|
| |
|
Software
|
| |
|
| |
|
Total cost
|
| |
|
| |
|
Less accumulated depreciation and amortization
|
| |
(
|
| |
(
|
Property and equipment, net
|
| |
$
|
| |
$
|
|
| |
March 31,
2024
|
| |
December 31,
2023
|
|
| |
(unaudited)
|
| |
(audited)
|
Accrued wages, commission and bonus
|
| |
$
|
| |
$
|
Accrued professional fees
|
| |
|
| |
|
Deferred financial advisory fees
|
| |
|
| |
|
Other liabilities
|
| |
|
| |
|
|
| |
$
|
| |
$
|
|
| |
March 31,
2024
|
| |
December 31,
2023
|
|
| |
(unaudited)
|
| |
(audited)
|
|
| |
$
|
| |
$
|
|
| |
|
| |
|
|
| |
$
|
| |
$
|
Less: Deferred financing fees, net
|
| |
(
|
| |
|
|
| |
$
|
| |
$
|
|
| |
Three Months Ended March 31,
|
|||
|
| |
2024
|
| |
2023
|
Revenue
|
| |
|
| |
|
Brand revenue
|
| |
$
|
| |
$
|
Retail revenue
|
| |
|
| |
|
Total revenue
|
| |
$
|
| |
$
|
|
| |
Three Months Ended March 31,
|
|||
|
| |
2024
|
| |
2023
|
Brand revenue
|
| |
|
| |
|
United States
|
| |
$
|
| |
$
|
Canada
|
| |
|
| |
|
Retail revenue
|
| |
|
| |
|
United States
|
| |
|
| |
|
Canada
|
| |
|
| |
|
|
| |
$
|
| |
$
|
|
| |
March 31,
2024
|
| |
December 31,
2023
|
|
| |
(unaudited)
|
| |
(audited)
|
Deferred sales commissions
|
| |
$
|
| |
$
|
|
| |
March 31,
2024
|
| |
December 31,
2023
|
|
| |
(unaudited)
|
| |
(audited)
|
Contract assets at start of the period
|
| |
$
|
| |
$
|
Expense deferred during the period
|
| |
|
| |
|
(Less) amounts expensed during the period
|
| |
(
|
| |
(
|
Contract assets at end of the period
|
| |
$
|
| |
$
|
|
| |
Options Outstanding
|
| |
Options Vested and Exercisable
|
|||||||||
|
| |
Number of
Options
|
| |
Weighted Average
Exercise Price
(Per Share)
|
| |
Number of
Options
|
| |
Weighted Average
Remaining
Contractual Life
(Years)
|
| |
Weighted Average
Exercise Price
(Per Share)
|
Outstanding Balance, January 1, 2024
|
| |
|
| |
$
|
| |
|
| |
|
| |
$
|
Options granted
|
| |
|
| |
|
| |
|
| |
|
| |
|
Options exercised
|
| |
|
| |
$
|
| |
|
| |
|
| |
|
Options forfeited
|
| |
(
|
| |
$
|
| |
|
| |
|
| |
|
Options cancelled
|
| |
|
| |
$
|
| |
|
| |
|
| |
|
Outstanding Balance, March 31, 2024
|
| |
|
| |
$
|
| |
|
| |
|
| |
$
|
|
| |
Restricted Stock Units Outstanding
|
||||||
|
| |
Number of
RSUs
|
| |
Weighted Average
Fair Value
(Per Share)
|
| |
Weighted Average
Vesting
(Years)
|
Outstanding Balance, December 31, 2022
|
| |
|
| |
$
|
| |
|
RSUs granted
|
| |
|
| |
|
| |
|
RSUs forfeited
|
| |
(
|
| |
|
| |
|
RSUs vested and common stock issued
|
| |
(
|
| |
$
|
| |
|
Outstanding Balance, December 31, 2023
|
| |
|
| |
$
|
| |
|
RSUs forfeited
|
| |
(
|
| |
|
| |
|
Outstanding Balance, March 31, 2024
|
| |
|
| |
$
|
| |
|
|
| |
March 31,
2024
|
| |
December 31,
2023
|
|
| |
(unaudited)
|
| |
(audited)
|
Balance Sheet
|
| |
|
| |
|
Assets:
|
| |
|
| |
|
Right of use asset - operating lease
|
| |
$
|
| |
$
|
Liabilities
|
| |
|
| |
|
Current
|
| |
|
| |
|
Non-current
|
| |
|
| |
|
Total operating lease liability
|
| |
$
|
| |
$
|
|
| |
Three Months Ended
March 31, 2024
|
| |
Three Months Ended
March 31, 2023
|
Other information
|
| |
|
| |
|
Operating lease cost
|
| |
$
|
| |
$
|
Operating cash flows paid to operating leases
|
| |
$
|
| |
$
|
Right-of-use assets in exchange for new operating lease liabilities
|
| |
$
|
| |
$
|
Weighted-average remaining lease term — operating leases (months)
|
| |
|
| |
|
Weighted-average discount rate — operating leases
|
| |
|
| |
|
|
| |
Level 1
|
| |
Level 2
|
| |
Level 3
|
| |
Total Fair Value
|
Liabilities:
|
| |
|
| |
|
| |
|
| |
|
Public warrants
|
| |
|
| |
|
| |
|
| |
|
|
| |
$
|
| |
$
|
| |
$
|
| |
$
|
|
| |
Level 1
|
| |
Level 2
|
| |
Level 3
|
| |
Total Fair Value
|
Liabilities:
|
| |
|
| |
|
| |
|
| |
|
Public warrants
|
| |
|
| |
|
| |
|
| |
|
|
| |
$
|
| |
$
|
| |
$
|
| |
$
|
Warrants
|
| |
|
Balance, January 1, 2024
|
| |
$
|
Change in fair value
|
| |
|
Balance, March 31, 2024
|
| |
$
|
Changes in fair value included in earnings for the period relating to
liabilities held at March 31, 2024
|
| |
$
|
a.
|
|
b.
|
|
c.
|
|
|
| |
Three Months Ended March 31,
|
|||
|
| |
2024
|
| |
2023
|
Numerator:
|
| |
|
| |
|
Net income (loss) for basic net income (loss) calculation
|
| |
$
|
| |
$(
|
Effect of dilutive securities:
|
| |
|
| |
|
Interest expense on Convertible Notes
|
| |
|
| |
|
Net income (loss) for diluted net income (loss) calculation
|
| |
$
|
| |
$(
|
|
| |
Three Months Ended March 31,
|
|||
|
| |
2024
|
| |
2023
|
Denominator
|
| |
|
| |
|
Denominator for basic net income (loss) per share, weighted average
|
| |
|
| |
|
Effect of dilutive securities:
|
| |
|
| |
|
Convertible notes stock conversion, weighted average as converted
|
| |
|
| |
|
Denominator for diluted net income per share
|
| |
|
| |
|
Net income (loss) per common share
|
| |
|
| |
|
Basic
|
| |
$
|
| |
$(
|
Diluted
|
| |
$
|
| |
$(
|
|
| |
Three Months Ended March 31,
|
|||
|
| |
2024
|
| |
2023
|
Shares unvested and subject to exercise of stock options
|
| |
|
| |
|
Shares subject to outstanding common stock options
|
| |
|
| |
|
Shares subject to convertible notes stock conversion
|
| |
|
| |
|
Shares subject to warrants stock conversion
|
| |
|
| |
|
Shares subject to contingent earn out
|
| |
|
| |
|
Restricted stock units
|
| |
|
| |
|
|
| |
December 31,
|
|||
|
| |
2023
|
| |
2022
|
|
| |
(In thousands except share data)
|
|||
ASSETS
|
| |
|
| |
|
Assets
|
| |
|
| |
|
Current assets:
|
| |
|
| |
|
Cash and cash equivalents
|
| |
$
|
| |
$
|
Accounts receivable, net
|
| |
|
| |
|
Contract assets
|
| |
|
| |
|
Prepaid expenses and other current assets
|
| |
|
| |
|
Total current assets
|
| |
|
| |
|
Operating lease assets
|
| |
|
| |
|
Property and equipment, net
|
| |
|
| |
|
Convertible note receivable
|
| |
|
| |
|
Total assets
|
| |
$
|
| |
$
|
|
| |
|
| |
|
LIABILITIES AND STOCKHOLDERS’ DEFICIT
|
| |
|
| |
|
Liabilities
|
| |
|
| |
|
Current liabilities:
|
| |
|
| |
|
Accounts payable
|
| |
$
|
| |
$
|
Accrued expense and other current liabilities
|
| |
|
| |
|
Short-term cash advances
|
| |
|
| |
|
Current maturities of long-term debt
|
| |
|
| |
|
Deferred payroll tax credits
|
| |
|
| |
|
Deferred revenue
|
| |
|
| |
|
Related party payable
|
| |
|
| |
|
Operating lease liabilities - current
|
| |
|
| |
|
Total current liabilities
|
| |
|
| |
|
Long-term debt, non-current
|
| |
|
| |
|
Operating lease liabilities - non-current
|
| |
|
| |
|
Warrant liabilities
|
| |
|
| |
|
Total liabilities
|
| |
|
| |
|
|
| |
|
| |
|
Commitments and Contingencies
|
| |
|
| |
|
|
| |
|
| |
|
Stockholders’ Deficit
|
| |
|
| |
|
Common stock par value $
|
| |
|
| |
|
Additional paid-in capital
|
| |
|
| |
|
Accumulated deficit
|
| |
(
|
| |
(
|
Total stockholders’ deficit
|
| |
(
|
| |
(
|
Total liabilities and stockholders’ deficit
|
| |
$
|
| |
$
|
|
| |
Years Ended December 31,
|
|||
|
| |
2023
|
| |
2022
|
|
| |
(In thousands except share data)
|
|||
|
| |
|
| |
|
Revenues
|
| |
$
|
| |
$
|
Cost of revenues
|
| |
|
| |
|
Gross profit
|
| |
|
| |
|
Operating expenses
|
| |
|
| |
|
Selling, servicing and marketing
|
| |
|
| |
|
Technology and software development
|
| |
|
| |
|
General and administrative
|
| |
|
| |
|
Total operating expenses
|
| |
|
| |
|
|
| |
|
| |
|
Loss from operations
|
| |
(
|
| |
(
|
Interest income
|
| |
|
| |
|
Interest expense
|
| |
(
|
| |
(
|
Change in fair value of warrants
|
| |
|
| |
|
Loss before income tax
|
| |
(
|
| |
(
|
Income tax expense
|
| |
|
| |
|
Net loss
|
| |
$(
|
| |
$(
|
Net loss per common share:
|
| |
|
| |
|
Basic and diluted
|
| |
$(
|
| |
$(
|
Weighted-average common shares outstanding
|
| |
|
| |
|
Basic and diluted
|
| |
|
| |
|
|
| |
Common Stock
|
| |
Additional Paid-in
Capital
|
| |
Accumulated
Deficit
|
| |
Total
|
|||
|
| |
Shares
|
| |
Amount
|
| |
Amount
|
| |
Amount
|
| |
Amount
|
|
| |
(In thousands except share data)
|
||||||||||||
Balance at December 31, 2021
|
| |
|
| |
$
|
| |
$
|
| |
$(
|
| |
$
|
Stock-based compensation
|
| |
—
|
| |
—
|
| |
|
| |
—
|
| |
|
Exercise of stock options
|
| |
|
| |
—
|
| |
|
| |
—
|
| |
|
Recapitalization
|
| |
|
| |
|
| |
|
| |
—
|
| |
|
Lease standard adoption
|
| |
—
|
| |
—
|
| |
—
|
| |
(
|
| |
(
|
Issue of common stock(1)
|
| |
|
| |
—
|
| |
—
|
| |
—
|
| |
—
|
Issue of common stock(2)
|
| |
|
| |
—
|
| |
|
| |
—
|
| |
|
Net loss
|
| |
—
|
| |
—
|
| |
|
| |
(
|
| |
(
|
Balance at December 31, 2022
|
| |
|
| |
$
|
| |
$
|
| |
$(
|
| |
$(
|
Stock-based compensation
|
| |
—
|
| |
—
|
| |
|
| |
—
|
| |
|
Exercise of stock options
|
| |
|
| |
—
|
| |
|
| |
—
|
| |
|
Issue of common stock(3)
|
| |
|
| |
|
| |
|
| |
—
|
| |
|
Issue of common stock(2)
|
| |
|
| |
—
|
| |
|
| |
—
|
| |
|
Issue of common stock(4)
|
| |
|
| |
—
|
| |
|
| |
—
|
| |
|
Issue of common stock(5)
|
| |
|
| |
—
|
| |
|
| |
—
|
| |
|
RSU vesting
|
| |
|
| |
—
|
| |
—
|
| |
—
|
| |
—
|
Net loss
|
| |
—
|
| |
—
|
| |
—
|
| |
(
|
| |
(
|
Balance at December 31, 2023
|
| |
|
| |
$
|
| |
$
|
| |
$(
|
| |
$(
|
(1)
|
|
(2)
|
|
(3)
|
|
(4)
|
|
(5)
|
|
|
| |
Years Ended December 31,
|
|||
|
| |
2023
|
| |
2022
|
|
| |
(In thousands)
|
|||
Cash flows from operating activities:
|
| |
|
| |
|
Net loss
|
| |
$(
|
| |
$(
|
Adjustments to reconcile net loss to net cash used in operating activities:
|
| |
|
| |
|
Depreciation and amortization
|
| |
|
| |
|
Discount amortization on convertible notes
|
| |
|
| |
|
Stock-based compensation expense
|
| |
|
| |
|
Amortization of operating lease right of use assets
|
| |
|
| |
|
Bad debt expense
|
| |
|
| |
|
Convertible note impairment
|
| |
|
| |
|
Abandoned software implementation assets
|
| |
|
| |
|
Accrued interest on convertible notes
|
| |
|
| |
|
Change in fair value of warrants
|
| |
(
|
| |
(
|
Changes in operating assets and liabilities:
|
| |
|
| |
|
Accounts receivable
|
| |
(
|
| |
(
|
Prepaid expenses and other current assets
|
| |
|
| |
(
|
Contract assets
|
| |
|
| |
|
Accounts payable and other liabilities
|
| |
|
| |
|
Operating lease liabilities
|
| |
(
|
| |
(
|
Deferred payroll tax credits
|
| |
|
| |
|
Deferred revenue
|
| |
(
|
| |
(
|
Net cash used in operating activities
|
| |
(
|
| |
(
|
Cash flows from investing activities:
|
| |
|
| |
|
Purchase of convertible note
|
| |
|
| |
(
|
Purchases of property and equipment
|
| |
(
|
| |
(
|
Net cash used in investing activities
|
| |
(
|
| |
(
|
Cash flows from financing activities:
|
| |
|
| |
|
Business combination, net of transaction cost
|
| |
|
| |
|
Proceeds from short-term cash advance
|
| |
|
| |
|
Repayment of short-term cash advance
|
| |
(
|
| |
|
Proceeds from related party payable
|
| |
|
| |
|
Related party repayments
|
| |
(
|
| |
|
Proceeds from convertible notes
|
| |
|
| |
|
Repayment of convertible notes
|
| |
(
|
| |
(
|
Proceeds from the issuance of common stock
|
| |
|
| |
|
Cost of equity issuance
|
| |
(
|
| |
|
Proceeds from exercise of stock options
|
| |
|
| |
|
Net cash provided by financing activities
|
| |
|
| |
|
Net increase (decrease) in cash and cash equivalents
|
| |
$(
|
| |
$
|
Cash and cash equivalents at beginning of period
|
| |
|
| |
|
Cash and cash equivalents at end of period
|
| |
$
|
| |
$
|
Supplemental cash flows disclosures
|
| |
|
| |
|
Income taxes paid
|
| |
$
|
| |
$
|
Interest paid
|
| |
$
|
| |
$
|
Supplemental disclosure of non-cash activities
|
| |
|
| |
|
Conversion of convertible notes and interest into common stock
|
| |
$
|
| |
$
|
Warrants assumed in business combination at estimated fair value
|
| |
$
|
| |
$
|
Conversion of L1 Notes into common stock
|
| |
$
|
| |
$
|
Right of use assets obtained in exchange for lease obligations - operating
leases
|
| |
$
|
| |
$
|
Related party payments on accounts payable
|
| |
$
|
| |
$
|
Common stock issued for services rendered
|
| |
$
|
| |
$
|
Settlement of litigation through issuance of common stock
|
| |
$
|
| |
$
|
|
| |
December 31,
|
|||
|
| |
2023
|
| |
2022
|
Accounts receivable
|
| |
$
|
| |
$
|
Unbilled receivables
|
| |
|
| |
|
Total receivables
|
| |
|
| |
|
Less allowance for credit losses
|
| |
(
|
| |
(
|
Accounts receivable, net
|
| |
$
|
| |
$
|
|
| |
Allowance for credit losses
|
Outstanding Balance, January 1, 2023
|
| |
$
|
Current-period provision (release) for expected credit losses
|
| |
|
Write-offs charged against the allowance, net of recoveries and other
|
| |
(
|
Outstanding Balance, December 31, 2023
|
| |
$
|
|
| |
December 31,
|
|||
|
| |
2023
|
| |
2022
|
Prepaid insurance
|
| |
$
|
| |
$
|
Other prepaid expenses
|
| |
|
| |
|
Deposits
|
| |
|
| |
|
|
| |
$
|
| |
$
|
|
| |
December 31,
|
|||
|
| |
2023
|
| |
2022
|
Computer equipment
|
| |
$
|
| |
$
|
Furniture and fixtures
|
| |
|
| |
|
Data warehouse
|
| |
|
| |
|
Software
|
| |
|
| |
|
Total Cost
|
| |
|
| |
|
Less accumulated depreciation and amortization
|
| |
(
|
| |
(
|
Property and Equipment
|
| |
$
|
| |
$
|
|
| |
December 31,
|
|||
|
| |
2023
|
| |
2022
|
Accrued wages, commission and bonus
|
| |
$
|
| |
$
|
Accrued professional fees
|
| |
|
| |
|
Deferred financial advisory fees
|
| |
|
| |
|
Other liabilities
|
| |
|
| |
|
|
| |
$
|
| |
$
|
Amount available after paying TCAC redeeming stockholders
|
| |
$
|
Proceeds from convertible notes
|
| |
|
Proceeds from PIPE Financing
|
| |
|
TCAC operating account
|
| |
|
Gross proceeds available at closing
|
| |
|
Expenses paid at closing
|
| |
(
|
Net cash to Legacy SpringBig at closing
|
| |
$
|
Post closing expense (cash paid or accrued for expenses by Legacy SpringBig)
|
| |
(
|
Net cash after closing
|
| |
$
|
TCAC non-redeeming shareholders
|
| |
|
PIPE Investors
|
| |
|
TCAC sponsor shareholders
|
| |
|
Legacy SpringBig shareholders
|
| |
|
Issued and outstanding
|
| |
|
|
| |
Year ended December 31,
|
|||
|
| |
2023
|
| |
2022
|
Revenue
|
| |
|
| |
|
Brand revenue
|
| |
$
|
| |
$
|
Retail revenue
|
| |
|
| |
|
Total Revenue
|
| |
$
|
| |
$
|
|
| |
Year ended December 31,
|
|||
|
| |
2023
|
| |
2022
|
Brand revenue
|
| |
|
| |
|
United States
|
| |
$
|
| |
$
|
Canada
|
| |
|
| |
|
Retail revenue
|
| |
|
| |
|
United States
|
| |
|
| |
|
Canada
|
| |
|
| |
|
|
| |
$
|
| |
$
|
|
| |
December 31,
|
|||
|
| |
2023
|
| |
2022
|
Deferred sales commissions
|
| |
$
|
| |
$
|
|
| |
December 31,
|
|||
|
| |
2023
|
| |
2022
|
Deferred retail revenues
|
| |
$
|
| |
$
|
Deferred brands revenues
|
| |
|
| |
|
Contract liabilities
|
| |
$
|
| |
$
|
|
| |
Year ended December 31,
|
|||
|
| |
2023
|
| |
2022
|
The movement in the contract liabilities during each period comprised the
following:
|
| |
|
| |
|
Contract liabilities at start of the period
|
| |
$
|
| |
$
|
Amounts invoiced during the period
|
| |
|
| |
|
Less revenue recognized during the period
|
| |
(
|
| |
(
|
Contract liabilities at end of the period
|
| |
$
|
| |
$
|
|
| |
Options Outstanding
|
| |
Options Vested and Exercisable
|
|||||||||
Fixed Options
|
| |
Number of
Options
|
| |
Weighted Average
Exercise Price
(Per Share)
|
| |
Number of
Options
|
| |
Weighted Average
Remaining
Contractual Life
(Years)
|
| |
Weighted Average
Exercise Price
(Per Share)
|
Outstanding Balance, January 1, 2022
|
| |
|
| |
$
|
| |
|
| |
|
| |
$
|
Options exercised
|
| |
(
|
| |
$
|
| |
|
| |
|
| |
|
Options forfeited
|
| |
(
|
| |
$
|
| |
|
| |
|
| |
|
Options cancelled
|
| |
(
|
| |
$
|
| |
|
| |
|
| |
|
Outstanding Balance, June 14, 2022
|
| |
|
| |
|
| |
|
| |
|
| |
|
Conversion ratio
|
| |
|
| |
|
| |
|
| |
|
| |
|
SpringBig Holdings options
|
| |
|
| |
|
| |
|
| |
|
| |
|
Options exercised
|
| |
(
|
| |
$
|
| |
|
| |
|
| |
|
Options forfeited | ( |
$
|
______ | ___ | ____ | ||||||||||
Outstanding Balance, January 1, 2023
|
| |
|
| |
$
|
| |
|
| |
|
| |
$
|
Options exercised
|
| |
(
|
| |
$
|
| |
|
| |
|
| |
|
Options forfeited
|
| |
(
|
| |
$
|
| |
|
| |
|
| |
|
Options cancelled
|
| |
(
|
| |
$
|
| |
|
| |
|
| |
|
Outstanding Balance, Dec. 31, 2023
|
| |
|
| |
$
|
| |
|
| |
|
| |
$
|
|
| |
Restricted Stock Units Outstanding
|
||||||
|
| |
Number of
RSUs
|
| |
Weighted Average
Fair Value
(Per Share)
|
| |
Weighted Average
Vesting (Years)
|
Outstanding Balance, January 1, 2022
|
| |
|
| |
|
| |
|
RSUs granted
|
| |
|
| |
$
|
| |
|
RSUs forfeited
|
| |
(
|
| |
$
|
| |
|
Outstanding Balance, January 1, 2023
|
| |
|
| |
$
|
| |
|
RSUs granted
|
| |
|
| |
$
|
| |
|
RSUs forfeited
|
| |
(
|
| |
$
|
| |
|
RSUs vested and common stock issued
|
| |
(
|
| |
$
|
| |
|
Outstanding Balance, December 31, 2023
|
| |
|
| |
$
|
| |
|
|
| |
Year ended December 31,
|
|||
|
| |
2023
|
| |
2022
|
Balance Sheet
|
| |
|
| |
|
Assets:
|
| |
|
| |
|
Right of Use Assets - Operating Lease
|
| |
$
|
| |
$
|
Liabilities:
|
| |
|
| |
|
Current
|
| |
|
| |
|
Non-current
|
| |
|
| |
|
Total Operating Lease Liabilities
|
| |
$
|
| |
$
|
|
| |
2023
|
| |
2022
|
Other information
|
| |
|
| |
|
Operating lease cost
|
| |
$
|
| |
$
|
Operating cash flows from operating leases
|
| |
$
|
| |
$
|
Disposal of right-of-use assets
|
| |
$
|
| |
$
|
Disposal of operating lease liabilities associated with right-of-use assets
|
| |
$
|
| |
$
|
Right-of-use assets obtained in exchange for new operating lease liabilities
|
| |
$
|
| |
$
|
Weighted-average remaining lease term - operating leases (months)
|
| |
|
| |
|
Weighted-average discount rate - operating leases
|
| |
|
| |
|
|
| |
Operating Leases
|
Fiscal Year:
|
| |
|
2024
|
| |
$
|
2025
|
| |
|
2026
|
| |
|
2027
|
| |
|
Total lease payments
|
| |
|
Less imputed interest
|
| |
(
|
Present value of lease liabilities
|
| |
$
|
For the year ended December 31, 2022
|
| |
Level 1
|
| |
Level 2
|
| |
Level 3
|
| |
Total Fair Value
|
Liabilities:
|
| |
|
| |
|
| |
|
| |
|
Public warrants
|
| |
|
| |
|
| |
|
| |
|
|
| |
$
|
| |
$
|
| |
$
|
| |
$
|
For the year ended December 31, 2023
|
| |
Level 1
|
| |
Level 2
|
| |
Level 3
|
| |
Total Fair Value
|
Liabilities:
|
| |
|
| |
|
| |
|
| |
|
Public warrants
|
| |
|
| |
|
| |
|
| |
|
|
| |
$
|
| |
$
|
| |
$
|
| |
$
|
Warrants
|
| |
|
Balance, January 1, 2022
|
| |
$
|
Assumed in business combination at fair value
|
| |
$
|
Change in value
|
| |
$(
|
Balance, December 31, 2022
|
| |
$
|
Changes in fair value included in earnings for the period
relating to liabilities held at December 31, 2022
|
| |
$(
|
|
| |
|
Balance, January 1, 2023
|
| |
$
|
Change in fair value
|
| |
(
|
Balance, December 31, 2023
|
| |
$
|
Changes in fair value included in earnings for the period
relating to liabilities held at December 31, 2023
|
| |
$(
|
|
| |
Legacy SpringBig
|
| |
Conversion Rate
|
| |
SpringBig
|
Series B Preferred
|
| |
|
| |
|
| |
|
Series A Preferred
|
| |
|
| |
|
| |
|
Series Seed Preferred
|
| |
|
| |
|
| |
|
Common Stock
|
| |
|
| |
|
| |
|
|
| |
|
| |
|
| |
|
a.
|
|
b.
|
|
c.
|
|
|
| |
Years Ended December 31,
|
|||
|
| |
2023
|
| |
2022
|
Loss per share:
|
| |
|
| |
|
Numerator:
|
| |
|
| |
|
Net loss
|
| |
$(
|
| |
$(
|
Denominator
|
| |
|
| |
|
Weighted-average common shares outstanding
|
| |
|
| |
|
Basic and diluted
|
| |
|
| |
|
Net loss per common share
|
| |
|
| |
|
Basic and diluted
|
| |
$(
|
| |
$(
|
|
| |
Years Ended December 31,
|
|||
|
| |
2023
|
| |
2022
|
Shares unvested and subject to exercise of stock options
|
| |
|
| |
|
Shares subject to outstanding common stock options
|
| |
|
| |
|
Shares subject to convertible notes stock conversion
|
| |
|
| |
|
Shares subject to warrants stock conversion
|
| |
|
| |
|
Shares subject to contingent earn out
|
| |
|
| |
|
Restricted stock units
|
| |
|
| |
|
|
| |
Years Ended December 31,
|
|||
|
| |
2023
|
| |
2022
|
Loss from operations
|
| |
|
| |
|
U.S.
|
| |
$(
|
| |
$(
|
Foreign
|
| |
(
|
| |
(
|
|
| |
$(
|
| |
$(
|
|
| |
Years Ended December 31,
|
|||
|
| |
2023
|
| |
2022
|
Provision (benefit) for income taxes
|
| |
|
| |
|
Current
|
| |
|
| |
|
Federal
|
| |
$
|
| |
$
|
State
|
| |
|
| |
|
International
|
| |
|
| |
|
|
| |
$
|
| |
$
|
|
| |
December 31, 2023
|
| |
December 31, 2022
|
||||||
|
| |
Amount
|
| |
Rate
|
| |
Amount
|
| |
Rate
|
U.S. federal income tax provision (benefit) at statutory rate
|
| |
$(
|
| |
|
| |
$(
|
| |
|
Increase (decrease) in taxes resulting from:
|
| |
|
| |
|
| |
|
| |
|
State income tax expense
|
| |
|
| |
|
| |
|
| |
|
Foreign income and losses taxed at different rates
|
| |
(
|
| |
|
| |
(
|
| |
|
Change in valuation allowance
|
| |
|
| |
(
|
| |
|
| |
(
|
Non-deductible or non-taxable items
|
| |
|
| |
|
| |
(
|
| |
|
Foreign income taxes
|
| |
|
| |
|
| |
|
| |
|
Effect of income tax rate changes on deferred items
|
| |
|
| |
|
| |
|
| |
|
Provision (benefit) for income taxes
|
| |
$
|
| |
|
| |
$
|
| |
|
|
| |
Years Ended December 31,
|
|||
|
| |
2023
|
| |
2022
|
Deferred tax assets:
|
| |
|
| |
|
Accrued expenses and other liabilities
|
| |
$
|
| |
$
|
Net operating loss - US Federal
|
| |
|
| |
|
Net operating loss - US State
|
| |
|
| |
|
Net operating loss - Foreign
|
| |
|
| |
|
Property and equipment, net
|
| |
|
| |
|
Operating lease liability
|
| |
|
| |
|
Research and development
|
| |
|
| |
|
Stock based compensation
|
| |
|
| |
|
Total gross deferred tax assets
|
| |
$
|
| |
$
|
Less: valuation allowance
|
| |
(
|
| |
(
|
Total deferred tax assets
|
| |
|
| |
|
Deferred tax liabilities:
|
| |
|
| |
|
Prepaid expenses and other assets
|
| |
$(
|
| |
$(
|
Operating lease right of use asset
|
| |
(
|
| |
(
|
Property and equipment, net
|
| |
(
|
| |
|
Total deferred tax liabilities
|
| |
(
|
| |
(
|
Net deferred income tax asset (liability)
|
| |
$
|
| |
$
|
Item 13.
|
Other Expenses of Issuance and Distribution.
|
|
| |
Amount
|
SEC registration fee
|
| |
$958.87
|
Legal fees and expenses
|
| |
$25,000
|
Accounting fees and expenses
|
| |
$*
|
Financial printing and miscellaneous
|
| |
$*
|
Total
|
| |
$*
|
*
|
Estimates not presently known.
|
Item 14.
|
Indemnification of Directors and Officers.
|
Item 15.
|
Recent Sales of Unregistered Securities.
|
•
|
Tuatara’s sponsor purchased an aggregate of 6,000,000 private placement warrants for a purchase price of $1.00 per warrant in
a private placement that occurred simultaneously with the closing of the initial public offering. Each private placement warrant may be exercised for one Common Shares at a price of $11.50 per share, subject to adjustment. The private
placement warrants (including the shares issuable upon exercise of the private placement warrants) may not, subject to certain limited exceptions, be transferred, assigned or sold by it until 30 days after the completion of the initial
business combination.
|
•
|
On June 14, 2022, at the first closing under the Notes and Warrants Purchase Agreement, we issued and sold to L1 (i) a Note
in the principal amount of $11,000,000 and (ii) a five-year warrant to purchase 586,980 shares of our Common Stock at an exercise price of $12.00 per share, for total cash consideration to the Company of $10,000,000
|
•
|
On June 14, 2022, we issued 1,310,000 Common Shares pursuant to the Subscription Agreements entered into in connection with
the PIPE Subscription Financing for aggregate consideration of $13.1 million, plus 31,356 shares paid to certain investors pursuant to the convertible notes with such investors.
|
•
|
On September 9, 2022, we issued 877,193 shares of our Common Stock (such shares, the “Commitment Fee Shares”) to Cantor. We
issued the Commitment Fee Shares as consideration for Cantor’s irrevocable commitment to purchase additional shares of Common Stock at our election in our sole discretion, from time to time upon the terms and subject to the satisfaction
of the conditions set forth in the Common Stock Purchase Agreement. The Common Stock Purchase Agreement established a committed equity facility pursuant to which we may in the future, from time to time, at our election in our sole
discretion, upon the terms and subject to the satisfaction of the conditions set forth in the Common Stock Purchase Agreement issue and sell to the Cantor additional shares of our Common Stock. Effective as of August 30, 2023, the
Common Stock Purchase Agreement was terminated in accordance with its terms.
|
•
|
On December 2, 6, 9, and 13, 2022, we issued 80,770, 80,770, 91,481, and 98,224, respectively, for a total of 351,245 shares
of our Common Stock (such shares, the “L1 Shares”) to the Investor. We issued the L1 Shares as consideration for repayment of a portion of the amounts payable under the L1 Notes.
|
•
|
Effective September 13, 2023, pursuant to the Settlement Agreement, the Company issued 1,700,000 shares of our Common Stock,
in the aggregate to Michael Gross and Jason Wright, which did not involve any underwriters, underwriting discounts or commissions, or any public offering.
|
•
|
Effective September 29, 2023, the Company issued 150,000 shares of common stock to Douglas J. Stukel in exchange for services
rendered to the Company, which did not involve any underwriters, underwriting discounts or commissions, or any public offering.
|
•
|
Effective November 15, 2023, the Company issued 286,260 shares of common stock to Michael Faber in exchange for services
rendered to the Company, which did not involve any underwriters, underwriting discounts or commissions, or any public offering.
|
•
|
In connection with the Debt Settlement Agreement on January 16, 2024, the Company issued 1,000,000 shares of Common Stock to
the Holder, which did not involve any underwriters, underwriting discounts or commissions, or any public offering.
|
•
|
On January 23, 2024, we issued a total of $6.4 million of 8% Senior Secured Convertible Promissory Notes due 2026 and (ii) a
total of $1.6 million of 12% Senior Secured Term Promissory Notes due 2026 in a private placement with the purchasers party thereto. The issuances of the Convertible Notes and Term Notes did not involve any public offering. The Company
completed these issuances in a transaction not requiring registration under Section 5 of the Securities Act, in reliance on the exemption afforded by Section 4(a)(2) thereof and/or Rule 506(b) of Regulation D promulgated thereunder.
|
Item 16.
|
Exhibits.
|
Exhibit Number
|
| |
Exhibit Description
|
| |
Form
|
| |
Exhibit
|
| |
Filing Date
|
| |
SEC
File #
|
2.1
|
| | | |
Proxy Statement /
Prospectus
|
| |
Annex A
|
| |
May 17, 2022
|
| |
333-262628
|
|
3.1
|
| | | |
10-K
|
| |
3.1
|
| |
March 28, 2023
|
| |
001-40049
|
|
3.2
|
| | | |
10-K
|
| |
3.2
|
| |
March 28, 2023
|
| |
001-40049
|
|
4.1
|
| | | |
8-K
|
| |
4.1
|
| |
June 21, 2022
|
| |
001-40049
|
|
4.2
|
| | | |
8-K
|
| |
4.2
|
| |
June 21, 2022
|
| |
001-40049
|
|
4.3
|
| | | |
8-K/A
|
| |
10.1
|
| |
December 1, 2022
|
| |
001-40049
|
|
4.4
|
| | | |
8-K
|
| |
4.1
|
| |
February 17, 2021
|
| |
001-40049
|
|
4.5
|
| | | |
8-K
|
| |
4.1
|
| |
January 24, 2024
|
| |
001-40049
|
|
4.6
|
| | | |
8-K
|
| |
4.2
|
| |
January 24, 2024
|
| |
001-40049
|
|
5.1*
|
| | | |
|
| |
|
| |
|
| |
|
|
10.1
|
| | | |
8-K
|
| |
10.1
|
| |
June 21, 2022
|
| |
001-40049
|
|
10.2
|
| | | |
8-K
|
| |
10.2
|
| |
June 21, 2022
|
| |
001-40049
|
|
10.3
|
| | | |
8-K
|
| |
10.2
|
| |
November 9, 2021
|
| |
001-40049
|
|
10.4
|
| | | |
8-K
|
| |
10.1
|
| |
May 2, 2022
|
| |
001-40049
|
|
10.5
|
| | | |
8-K
|
| |
10.5
|
| |
June 21, 2022
|
| |
001-40049
|
|
10.6#
|
| | | |
8-K
|
| |
10.6
|
| |
June 21, 2022
|
| |
001-40049
|
|
10.7#
|
| | | |
8-K
|
| |
10.7
|
| |
June 21, 2022
|
| |
001-40049
|
Exhibit Number
|
| |
Exhibit Description
|
| |
Form
|
| |
Exhibit
|
| |
Filing Date
|
| |
SEC
File #
|
10.8#
|
| | | |
8-K
|
| |
10.8
|
| |
June 21, 2022
|
| |
001-40049
|
|
10.9†
|
| | | |
8-K
|
| |
10.2
|
| |
May 2, 2022
|
| |
001-40049
|
|
10.10
|
| | | |
8-K
|
| |
10.3
|
| |
May 2, 2022
|
| |
001-40049
|
|
10.11†
|
| | | |
S-1
|
| |
10.11
|
| |
July 22, 2022
|
| |
333-266293
|
|
10.12
|
| | | |
8-K/A
|
| |
10.1
|
| |
December 1, 2022
|
| |
001-40049
|
|
10.13
|
| | | |
8-K
|
| |
10.1
|
| |
December 29, 2022
|
| |
001-40049
|
|
10.14
|
| | | |
8-K
|
| |
10.1
|
| |
September 13, 2023
|
| |
001-40049
|
|
10.15
|
| | | |
10-Q
|
| |
10.2
|
| |
November 13, 2023
|
| |
001-40049
|
|
10.16
|
| | | |
10-Q
|
| |
10.3
|
| |
November 13, 2023
|
| |
001-40049
|
|
10.17
|
| | | |
8-K
|
| |
10.1
|
| |
January 24, 2024
|
| |
001-40049
|
|
10.18
|
| | | |
8-K
|
| |
10.2
|
| |
January 24, 2024
|
| |
001-40049
|
|
10.19
|
| | | |
8-K
|
| |
10.3
|
| |
January 24, 2024
|
| |
001-40049
|
|
10.20
|
| | | |
8-K
|
| |
10.1
|
| |
January 29, 2024
|
| |
001-40049
|
|
10.21
|
| | | |
DEF 14A
|
| |
Appendix B
|
| |
April 28, 2023
|
| |
001-40049
|
Exhibit Number
|
| |
Exhibit Description
|
| |
Form
|
| |
Exhibit
|
| |
Filing Date
|
| |
SEC
File #
|
10.22
|
| | | |
S-8
|
| |
99.2
|
| |
August 22, 2022
|
| |
333-267011
|
|
16.1
|
| | | |
8-K
|
| |
16.1
|
| |
April 11, 2024
|
| |
001-40049
|
|
21.1
|
| | | |
10-K
|
| |
21.1
|
| |
April 1, 2024
|
| |
001-40049
|
|
23.1*
|
| | | |
|
| |
|
| |
|
| |
|
|
23.2*
|
| | | |
|
| |
|
| |
|
| |
|
|
24.1*
|
| | | |
|
| |
|
| |
|
| |
|
|
101.INS*
|
| |
Inline XBRL Instance Document
|
| |
|
| |
|
| |
|
| |
|
101.SCH*
|
| |
Inline XBRL Taxonomy Extension Schema Document
|
| |
|
| |
|
| |
|
| |
|
101.CAL*
|
| |
Inline XBRL Taxonomy Extension Calculation Linkbase Document
|
| |
|
| |
|
| |
|
| |
|
101.DEF*
|
| |
Inline XBRL Taxonomy Extension Definition Linkbase Document
|
| |
|
| |
|
| |
|
| |
|
101.LAB*
|
| |
Inline XBRL Taxonomy Extension Label Linkbase Document
|
| |
|
| |
|
| |
|
| |
|
101.PRE*
|
| |
Inline XBRL Taxonomy Extension Presentation Linkbase Document
|
| |
|
| |
|
| |
|
| |
|
104*
|
| |
Cover Page Interactive Data File (formatted as Inline XBRL and contained in
Exhibit 101)
|
| |
|
| |
|
| |
|
| |
|
107*
|
| | | |
|
| |
|
| |
|
| |
|
*
|
Filed herewith.
|
#
|
Indicates management contract or compensatory plan or arrangement.
|
†
|
Schedules have been omitted pursuant to Item 601(a)(5) of Regulation S-K. The registrant hereby undertakes to furnish copies
of any of the omitted schedules upon request by the Securities and Exchange Commission.
|
Item 17.
|
Undertakings.
|
A.
|
To file, during any period in which offers or sales are being made, a post-effective amendment to this registration
statement:
|
(i)
|
To include any prospectus required by section 10(a)(3) of the Securities Act;
|
(ii)
|
To reflect in the prospectus any facts or events arising after the effective date of the registration statement (or the most
recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the registration statement. Notwithstanding the foregoing, any increase or decrease in
volume of securities offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of
prospectus filed with the SEC pursuant to Rule 424(b) if, in the aggregate, the changes in volume and price represent no more than 20% change in the maximum aggregate offering price set forth in the “Calculation of Registration Fee”
table in the effective registration statement.
|
(iii)
|
To include any material information with respect to the plan of distribution not previously disclosed in the registration
statement or any material change to such information in the registration statement;
|
B.
|
That, for the purpose of determining any liability under the Securities Act, each such post-effective amendment shall be
deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.
|
C.
|
To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold
at the termination of the offering.
|
D.
|
That, for the purpose of determining liability under the Securities Act to any purchaser, each prospectus filed pursuant to
Rule 424(b) as part of a registration statement relating to an offering, other than registration statements relying on Rule 430B or other than prospectuses filed in reliance on Rule 430A, shall be deemed to be part of and included in
the registration statement as of the date it is first used after effectiveness. Provided, however, that no statement made in a registration statement or prospectus that is part of the registration statement or made in a document
incorporated or deemed incorporated by reference into the registration statement or prospectus that is part of the registration statement will, as to a purchaser with a time of contract of sale prior to such first use, supersede or
modify any statement that was made in the registration statement or prospectus that was part of the registration statement or made in any such document immediately prior to such date of first use.
|
E.
|
That, for the purpose of determining liability of the registrant under the Securities Act to any purchaser in the initial
distribution of the securities, that in a primary offering of securities of the undersigned registrant pursuant to this registration statement, regardless of the underwriting method used to sell the securities to the purchaser, if the
securities are offered or sold to such purchaser by means of any of the following communications, the undersigned registrant will be a seller to the purchaser and will be considered to offer or sell such securities to such purchaser:
|
(i)
|
Any preliminary prospectus or prospectus of the undersigned registrant relating to the offering required to be filed pursuant
to Rule 424;
|
(ii)
|
Any free writing prospectus relating to the offering prepared by or on behalf of the undersigned registrant or used or
referred to by the undersigned registrant;
|
(iii)
|
The portion of any other free writing prospectus relating to the offering containing material information about the
undersigned registrant or its securities provided by or on behalf of the undersigned registrant; and (iv)Any other communication that is an offer in the offering made by the undersigned registrant to the purchaser.
|
F.
|
Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers and
controlling persons of the registrant pursuant to the foregoing provisions, or otherwise, the registrant has been advised that in the opinion of the SEC such indemnification is against public policy as expressed in the Securities Act
and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the registrant of expenses incurred or paid by a director, officer or controlling person of the
registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the registrant will, unless in the opinion of its
counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act and will be governed
by the final adjudication of such issue.
|
|
| |
SPRINGBIG HOLDINGS, INC.
|
||||||
|
| |
|
||||||
|
| |
By:
|
| |
/s/ Jeffrey Harris
|
|||
|
| |
|
| |
Name:
|
| |
Jeffrey Harris
|
|
| |
|
| |
Title:
|
| |
Chief Executive Officer
|
Name
|
| |
Title
|
| |
Date
|
|
|
| |
|
| |
|
|
/s/ Jeffrey Harris
|
| |
Chief Executive Officer and Chairman of the Board of Directors
(principal executive officer)
|
| |
June 20, 2024
|
|
Jeffrey Harris
|
| |
|
| |||
|
| |
|
| |
|
|
/s/ Paul Sykes
|
| |
Chief Financial Officer
(principal financial officer and
principal accounting officer)
|
| |
June 20, 2024
|
|
Paul Sykes
|
| |
|
| |||
|
| |
|
| |
|
|
/s/ Shawn Dym
|
| |
Director
|
| |
June 20, 2024
|
|
Shawn Dym
|
| |
|
| |||
|
| |
|
| |
|
|
/s/ Matt Sacks
|
| |
Director
|
| |
June 20, 2024
|
|
Matt Sacks
|
| |
|
| |||
|
| |
|
| |
|
|
/s/ Sergey Sherman
|
| |
Director
|
| |
June 20, 2024
|
|
Sergey Sherman
|
| |
|
| |
|
|
|
| |
|
| |
|
|
/s/ Mark Silver
|
| |
Director
|
| |
June 20, 2024
|
|
Mark Silver
|
| |
|
| |
|
(i)
|
The issuance of up to 16,000,000 shares of Common Stock as follows:
|
•
|
up to 6,000,000 shares of Common Stock (the “Private Warrant Shares”) issuable upon the exercise of certain outstanding private placement warrants (the “Private Warrants”) by the holders thereof; and
|
•
|
up to 10,000,000 shares of Common Stock (the “Public Warrant Shares” and, together with the Private Warrant Shares, the “Warrant Shares”) issuable upon the exercise of certain outstanding public offering warrants (together with the
Private Warrants, the “Warrants”) by the holders thereof.
|
(ii)
|
The resale of up to 21,590,291 shares of Common Stock (the “Original Selling Stockholder Shares” as follows:
|
•
|
1,341,356 shares of Common Stock issued in connection with a private placement pursuant to subscription agreements entered into on November 8, 2021 (the “Subscription Agreements”);
|
•
|
up to 4,000,000 shares of common stock (the “Founder Shares”) originally issued in a private placement to TCAC Sponsor, LLC (“TCAC Sponsor”) and certain affiliates pursuant to that certain Securities Purchase Agreement, dated February
10, 2020, by and among TCAC Sponsor and the Company, as amended and modified from time to time (the “Sponsor Purchase Agreement”) in connection with the Company’s initial public offering, including 1,000,000 Founder Shares subject to
vesting and forfeiture (the “Sponsor Vesting Shares”); and
|
•
|
16,248,935 shares of Common Stock issued pursuant to the Amended and Restated Agreement and Plan of Merger, dated as of April 14, 2022, as amended by the Amendment No. 1 to the Amended and Restated Agreement and Plan of Merger, dated as
of May 4, 2022, in each case, by and between Tuatara Capital Acquisition Corporation, an exempted company incorporated under the laws of the Cayman Islands, HighJump Merger Sub, Inc., a Delaware corporation, and SpringBig, Inc., a Delaware
corporation (the “Merger Agreement”).
|
(iii)
|
The resale of up to 6,000,000 Private Warrants.
|
(iv)
|
The resale of up to 1,700,000 shares of Common Stock (the “YB Stockholder Shares”) issued to certain holders in connection with the Settlement Agreement, dated September 7, 2023 (the “Settlement Agreement”), by and between Yuzz Buzz,
LLC, Jason Wright, and Michael Gross, on the one hand, and the Company, SpringBig, Inc., Medici Holdings V, Inc. (f/k/a SpringBig, Inc.) and Jeffrey Harris, on the other hand.
|
(v)
|
The resale of up to 436,260 shares of Common Stock (the “Service Stockholder Shares” and, together with the Original Selling Stockholder Shares and the YB Stockholder Shares, the “Selling Stockholder Shares”) issued to certain service
provider stockholders in relation to services rendered and to be rendered to the Company.
|
(vi)
|
The resale of up to 42,666,665 shares of Common Stock (the “Conversion Stockholder Shares”) reserved for issuance upon the conversion of the Company’s 8% Senior Secured Convertible Promissory Notes due 2026 (the “Convertible Notes”).
|
(a) |
each entity that is a party to the Transaction Documents has been duly organized or formed
|
(b) |
each of the Transaction Documents has been duly executed and delivered by, and constitutes the valid and binding obligation of each entity that is a party thereto, enforceable against such entity in accordance with its terms;
|
(c) |
each party to the Transaction Documents has performed and will perform such party’s obligations under the Transaction Documents; and
|
(d) |
the execution, delivery, and performance of the Transaction Documents and the consummation of the transactions contemplated by the Transaction Documents by each person that is or is to be a party thereto (i) do not violate any order
binding on, or judgment against, such person, and (ii) do not constitute a default under, and are not in conflict with, any indenture or other Purchase Agreement to which such person is a party or by which its properties may be bound.
|
A. |
The effect and application of bankruptcy, insolvency, fraudulent conveyance, reorganization, moratorium and other laws now or hereafter in effect which relate to or limit creditors’ rights and remedies generally;
|
B. |
The effect and application of general principles of equity, whether considered in a proceeding in equity or at law;
|
C. |
Limitations imposed by or resulting from the exercise by any court of its discretion; and
|
D. |
Limitations imposed by reason of generally applicable public policy principles or considerations.
|
|
Very truly yours,
/s/ Benesch Friedlander Coplan & Aronoff LLP
BENESCH, FRIEDLANDER,
COPLAN & ARONOFF LLP
|
|
|
|
|
|
SpringBig Holdings, Inc
|
|
Security Type
|
Security Class Title
|
Fee Calculation or Carry Forward Rule
|
Amount Registered (1)
|
Proposed Maximum Offering Price Per Share
|
Maximum Aggregate Offering Price
|
Fee Rate
|
Amount of Registration Fee
|
Carry Forward Form Type
|
Carry Forward File Number
|
Carry Forward Initial effective date
|
Filing Fee Previously Paid In Connection with Unsold Securities to be Carried Forward
|
|
Newly Registered Securities
|
||||||||||||
Fees to be Paid
|
Equity
|
Common Stock, par value
$0.0001 per share
|
457(c)
|
2,136,260(2)
|
$0.145(3)
|
$309,758
|
$.0001476
|
$45.72
|
||||
Fees to be Paid
|
Equity
|
Common Stock, par value
$0.0001 per share, issuable upon exercise of outstanding convertible notes
|
457(c)
|
42,666,665(4)
|
$0.145(3)
|
$6,186,666
|
$.0001476
|
$913.15
|
||||
Carry Forward Securities
|
||||||||||||
Carry Forward
Securities
|
Equity
|
Common Stock, par value $0.0001 per share
|
415(a)(6)
|
21,590,291(5)
|
$1.75(6)
|
(7)
|
|
|
S-1
|
333-266138
|
August 11, 2022
|
$3,502.48
|
Carry Forward
Securities
|
Equity
|
Common Stock,
$0.0001 par value per share, issuable upon exercise of outstanding warrants
|
415(a)(6)
|
16,000,000(8)
|
$11.50(9)
|
(10)
|
|
|
S-1
|
333-266138
|
August 11, 2022
|
$17,056.80
|
Carry Forward
Securities
|
Equity
|
Warrants to purchase shares of common stock
|
415(a)(6)
|
6,000,000(11)
|
– (11)
|
–
|
–
|
S-1
|
333-266138
|
August 11, 2022
|
–
|
|
Total Offering Amounts
|
$6,496,424
|
$958.87
|
||||||||||
Total Fees Previously Paid
|
|
|||||||||||
Total Fee Offsets
|
||||||||||||
Net Fee Due
|
$958.87
|
(1)
|
Pursuant to Rule 416 under the Securities Act of 1933, as amended, the shares of the Registrant's common stock being registered hereunder
include such indeterminate number of shares as may be issuable with respect to the shares being registered hereunder as a result of stock splits, stock dividends or similar transactions.
|
(2)
|
Consists of: (i) up to 1,700,000 shares of common stock issued to certain holders in connection with the Settlement Agreement, dated
September 7, 2023, by and between Yuzz Buzz, LLC, Jason Wright, and Michael Gross, on the one hand, and the Registrant, SpringBig, Inc., Medici Holdings V, Inc. (f/k/a SpringBig, Inc.), SpringBig Holdings, Inc. and Jeffrey Harris, on the
other hand, and (ii) up to 436,260 shares of common stock issued to certain service providers of the Registrant in exchange for services rendered and to be rendered.
|
(3)
|
Estimated solely for the purpose of calculating the registration fee pursuant to Rule 457(c) under the Securities Act, as amended, based on
the average of the high and low reported trading prices of the Registrant's common stock as reported on the OTCQX® Best Market on June 17, 2024.
|
(4)
|
Issuable upon conversion of the 8% Senior Secured Convertible Promissory Notes due 2026 issued on January 23, 2024 pursuant to a note
purchase agreement in a private placement with the purchasers party thereto.
|
(5)
|
Consists of up to 21,590,291 shares of common stock being registered for resale by the selling securityholders named in this registration
statement consisting of up to: (i) 1,341,356 shares of common stock purchased by subscribers in a private placement pursuant to separate subscription agreements, (ii) 4,000,000 shares of common stock originally issued in a private
placement to originally issued in a private placement to TCAC Sponsor, LLC, a Delaware limited liability company and certain affiliates in connection with the IPO of Tuatara Capital Acquisition Corporation (“Tuatara”), and (iii)
16,248,935 shares of common stock beneficially owned by certain stockholders who have been granted registration rights.
|
(6)
|
Estimated solely for the purpose of calculating the registration fee pursuant to Rule 457(c) under the Securities Act, as amended, based on
the average of the high and low reported trading prices of the Registrant's common stock as reported on the Nasdaq Capital Market on July 13, 2022.
|
(7)
|
Represents carry forward securities that remain unsold by the selling stockholders under the Registration Statement on Form S-1, filed on
July 15, 2022 (File No. 333-266138) (the “Prior Registration Statement”), and are included in this Registration Statement pursuant to Rule 415(a)(6). These securities consist of the securities described in note 5. An amount of $3,502.48
in filing fees previously paid in connection with such unsold shares under the Prior Registration Statement will continue to apply to such unsold shares included in this Registration Statement. The offering of such unsold securities
registered under the Prior Registration Statement will be deemed terminated as of the effective date of this Registration Statement.
|
(8)
|
Consists of up to 16,000,000 shares of common stock, consisting of up to: (i) 6,000,000 shares of common stock that may be issued upon the
exercise of 6,000,000 warrants (the “private placement warrants”) originally issued in a private placement in connection with the initial public offering of Tuatara, by the holders thereof, at an exercise price of $11.50 per share,
subject to adjustment, and (ii) 10,000,000 shares of common stock that may be issued upon the exercise of 10,000,000 warrants (the “public warrants”), originally issued in the initial public offering of Tuatara, by holders thereof, at an
exercise price of $11.50 per share, subject to adjustment.
|
(9)
|
Calculated pursuant to Rule 457(g) under the Securities Act, based on the $11.50 exercise price per share of common stock issuable upon exercise
of the public warrants and private placement warrants.
|
(10)
|
Represents carry forward securities that remain unsold under the Prior Registration Statement and are included in this Registration Statement
pursuant to Rule 415(a)(6). These securities consist of the securities described in note 8. Pursuant to Rule 415(a)(6) under the Securities Act, the filing fees previously paid in connection with such unsold securities will continue to be
applied to such unsold securities. Pursuant to Rule 415(a)(6), the offering of securities under the Prior Registration Statement will be deemed terminated as of the date of effectiveness of this registration statement.
|
(11)
|
Represents carry forward securities that remain unsold under the Prior Registration Statement and are included in this Registration Statement
pursuant to Rule 415(a)(6). These securities consist of 6,000,000 private placement warrants. In accordance with Rule 457(g), the entire registration fee for the private placement warrants is allocated to the shares of common stock
underlying the private placement warrants, and no separate fee is payable for the private placement warrants. Pursuant to Rule 415(a)(6), the offering of securities under the Prior Registration Statement will be deemed terminated as of the
date of effectiveness of this registration statement.
|